10-Q

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended July 1, 2017

Commission File Number 001-35672

BERRY GLOBAL GROUP, INC.

 A Delaware corporation  101 Oakley Street, Evansville, Indiana, 47710 (812) 424-2904  IRS employer identification number 20-5234618

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  Yes   No   

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes  No    

Indicate by check mark whether the registrant is a large accelerated filer, accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See definitions of " large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):   

Large accelerated filer         Accelerated filer       Non-accelerated filer  Smaller reporting company      Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.    Yes   ☐   No   ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).  

Yes     No  

Class	Outstanding at August 4, 2017
Common Stock, $.01 par value per share	130.4 million shares

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

This Form 10-Q includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to our financial condition, results of operations and business and our expectations or beliefs concerning future events.  The forward-looking statements include, in particular, statements about our plans, strategies and prospects under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations."  These statements contain words such as "believes," "expects," "may," "will," "should," "would," "could," "seeks," "approximately," "intends," "plans," "estimates," "outlook," "anticipates" or "looking forward" or similar expressions that relate to our strategy, plans, intentions, or expectations.  All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates and financial results or to our expectations regarding future industry trends are forward-looking statements.  In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments.  These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected.  We derive many of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions.  While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results.  All forward-looking statements are based upon information available to us on the date of this Form 10-Q. 

Readers should carefully review the factors discussed in our most recent Form 10-K in the section titled "Risk Factors" and other risk factors identified from time to time in our periodic filings with the Securities and Exchange Commission.

2

Berry Global Group, Inc.

Form 10-Q Index

For Quarterly Period Ended July 1, 2017

Part I.	Financial Information		Page No.
	Item 1.	Financial Statements:
		Consolidated Statements of Income and Comprehensive Income	4
		Consolidated Balance Sheets	5
		Consolidated Statements of Cash Flows	6
		Notes to Consolidated Financial Statements	7
	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	19
	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	26
	Item 4.	Controls and Procedures	27
Part II.	Other Information
	Item 1.	Legal Proceedings	28
	Item 1A.	Risk Factors	28
	Item 6.	Exhibits	29
	Signature		30

3

Part I. Financial Information

Item 1. Financial Statements

Berry Global Group, Inc.

Consolidated Statements of Income

(Unaudited)

(in millions of dollars, except per share amounts)

	Quarterly Period Ended						Three Quarterly Periods Ended
	July 1, 2017			July 2, 2016			July 1, 2017		July 2, 2016
Net sales	$	1,906		$	1,645		$	5,214	$	4,871
Costs and expenses:
Cost of goods sold		1,518			1,296			4,177		3,885
Selling, general and administrative		128			129			373		421
Amortization of intangibles		40			35			113		106
Restructuring and impairment charges		8			6			18		29
Operating income		212			179			533		430
Other (income) expense, net		(1	)		(14	)		18		(17	)
Interest expense, net		68			73			203		222
Income before income taxes		145			120			312		225
Income tax expense		38			24			82		66
Net income	$	107		$	96		$	230	$	159
Net income per share:
Basic	$	0.82		$	0.79		$	1.82	$	1.32
Diluted		0.79			0.76			1.75		1.28
Outstanding weighted-average shares:
Basic		129.9			121.1			126.6		120.5
Diluted		135.2			125.9			131.4		123.9

Berry Global Group, Inc.

Consolidated Statements of Comprehensive Income

(Unaudited)

(in millions of dollars) 

	Quarterly Period Ended						Three Quarterly Periods Ended
	July 1, 2017			July 2, 2016			July 1, 2017			July 2, 2016
Net income	$	107		$	96		$	230		$	159
Currency translation		24			(16	)		4			39
Defined benefit pension and retiree health benefit plans		—			—			13			—
Interest rate hedges		(1	)		(4	)		23			(20	)
Provision for income taxes related to other comprehensive  income items		—			1			(8	)		8
Other comprehensive income, net of tax		23			(19	)		32			27
Comprehensive income	$	130		$	77		$	262		$	186

See notes to consolidated financial statements.

4

Berry Global Group, Inc.

Consolidated Balance Sheets

(in millions of dollars)

	July 1, 2017			October 1, 2016
Assets	(Unaudited)
Current assets:
Cash and cash equivalents	$	275		$	323
Accounts receivable (less allowance of $13 and $8, respectively)		844			704
Inventories:
Finished goods		473			397
Raw materials and supplies		338			263
		811			660
Prepaid expenses and other current assets		92			105
Total current assets		2,022			1,792
Property, plant, and equipment, net		2,375			2,224
Goodwill and intangible assets, net		4,096			3,606
Other assets		52			31
Total assets	$	8,545		$	7,653
Liabilities
Current liabilities:
Accounts payable	$	581		$	539
Accrued expenses and other current liabilities		498			449
Current portion of long-term debt		34			43
Total current liabilities		1,113			1,031
Long-term debt, less current portion		5,857			5,712
Deferred income taxes		416			272
Other long-term liabilities		311			417
Total liabilities		7,697			7,432
Stockholders' equity
Common stock (130.4 and 122.0 million shares issued, respectively)		1			1
Additional paid-in capital		814			449
Non-controlling interest		3			3
Accumulated equity (deficit)		146			(84	)
Accumulated other comprehensive loss		(116	)		(148	)
Total stockholders' equity		848			221
Total liabilities and stockholders' equity	$	8,545		$	7,653

See notes to consolidated financial statements.

5

Berry Global Group, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

(in millions of dollars)

	Three Quarterly Periods Ended
	July 1, 2017			July 2, 2016
Cash Flows from Operating Activities:
Net income	$	230		$	159
Adjustments to reconcile net cash provided by operating activities:
Depreciation		270			284
Amortization of intangibles		113			106
Non-cash interest expense		6			8
Deferred income tax		39			23
Stock compensation expense		16			17
Other non-cash operating activities, net		26			(8	)
Changes in working capital		(113	)		(26	)
Changes in other assets and liabilities		(7	)		4
Net cash from operating activities		580			567
Cash Flows from Investing Activities:
Additions to property, plant and equipment		(201	)		(228	)
Proceeds from sale of assets		4			4
Acquisition of business, net of cash acquired		(515	)		(2,283	)
Other investing activities, net		(1	)		(11	)
Net cash from investing activities		(713	)		(2,518	)
Cash Flows from Financing Activities:
Proceeds from long-term borrowings		545			2,490
Repayments on long-term borrowings		(427	)		(390	)
Proceeds from issuance of common stock		26			20
Payment of tax receivable agreement		(60	)		(57	)
Debt financing costs		(4	)		(38	)
Purchase of non-controlling interest		—			(66	)
Net cash from financing activities		80			1,959
Effect of exchange rate changes on cash		5			—
Net change in cash		(48	)		8
Cash and cash equivalents at beginning of period		323			228
Cash and cash equivalents at end of period	$	275		$	236

See notes to consolidated financial statements.

6

Berry Global Group, Inc.

Notes to Consolidated Financial Statements

(Unaudited)

(tables in millions of dollars, except per share data)

1.  Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.  In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures at the date of the financial statements and during the reporting period.  Actual results could differ from those estimates.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated.  For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's most recent Form 10-K filed with the Securities and Exchange Commission.

Effective April 2017, the Company changed its name from Berry Plastics Group, Inc. to Berry Global Group, Inc.  The new name is reflected throughout this Form 10-Q.  Common Shares of the Company stock continue to be traded on the New York Stock Exchange under the symbol BERY.  In addition Berry Plastics Corporation, a wholly owned subsidiary, changed its name to Berry Global, Inc.

2. Recently Issued Accounting Pronouncements

Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates to the FASB's Accounting Standards Codification.  During fiscal 2017, with the exception of the below, there have been no developments to the recently adopted accounting pronouncements from those disclosed in the Company's 2016 Annual Report on Form 10-K that are considered to have a material impact on our unaudited consolidated financial statements.

Goodwill

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment.  To simplify the subsequent measurement of goodwill, Step 2, which was previously used to compute the implied fair value of goodwill, was eliminated.  This update requires an entity to perform its annual goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount.  An impairment will be recognized in the amount by which a reporting unit's carrying amount exceeds its fair value.  The loss recognized will not exceed the total amount of goodwill allocated to that reporting unit.  The new guidance is effective for interim and annual periods beginning after December 15, 2019 and should be applied on a prospective basis.  Early adoption is permitted.  We will adopt this guidance for our fiscal 2017 goodwill testing.

Retirement Benefits

In March 2017, the FASB issued ASU 2017-07, Compensation – Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which requires employers to report the service cost component in the same line item as other compensation costs arising from services rendered by the pertinent employees during the period.  The other components of net benefit cost are required to be presented in the income statement separately from the service cost component and outside a subtotal of income from operations. If a separate line item is used to present the other components of net benefit cost, then the line item used in the income statement to present the other components of net benefit cost must be disclosed.  The new guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied on a retrospective basis.  Early adoption is permitted.  The Company is currently evaluating the impact of this guidance.

3. Acquisitions

AEP Industries Inc.

In January 2017, the Company acquired AEP Industries Inc. ("AEP") for a purchase price of $791 million, net of cash acquired.  A portion of the purchase price consisted of issuing 6.4 million of Berry common shares which were valued at $324 million at the time of closing.  AEP manufactures and markets an extensive and diverse line of polyethylene and polyvinyl chloride flexible plastic packaging products for consumer, industrial, and agricultural applications.  The acquired business is operated in our Engineered Materials segment.  To finance the purchase, the Company entered into an incremental assumption agreement to increase the commitments under the Company's existing term loan credit agreement by $500 million due 2024.

7

The acquisition has been accounted for under the purchase method of accounting, and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary fair values at the acquisition date.  The results of AEP have been included in the consolidated results of the Company since the date of the acquisition.  The Company has not finalized the allocation of the purchase price to the fair value of the assets acquired and liabilities assumed.  The Company has recognized Goodwill on this transaction primarily as a result of expected cost synergies, and does not expect Goodwill to be deductible for tax purposes.  The following table summarizes the preliminary allocation of purchase price and the estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	133
Property and equipment		222
Intangible assets		214
Goodwill		350
Historical AEP debt assumed		(7	)
Other assets and long-term liabilities		(121	)
(a) Includes a $5 million step up of inventory to fair value

Unaudited pro forma net sales were $1.9 billion for the quarterly period ended July 2, 2016.  Unaudited pro forma net sales were $5.5 billion and $5.7 billion for the three quarterly periods ended July 1, 2017 and July 2, 2016, respectively.  Unaudited pro forma net income was $102 million for the quarterly period ended July 2, 2016.  Unaudited pro forma net income was $232 million and $175 million for the three quarterly periods ended July 1, 2017 and July 2, 2016, respectively.  The unaudited pro forma net sales and net income assume that the AEP acquisition had occurred as of the beginning of the period.

Adchem Corp.

In June 2017, the Company acquired Adchem Corp.'s ("Adchem") tapes business for a purchase price of $49 million.  Adchem is a leader in the development of high performance adhesive tape systems for the automotive, construction, electronics, graphic arts, medical and general tape markets.  The acquired business will be operated within the Engineered Materials segment.  To finance the purchase, the Company used existing liquidity.  The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary values at the acquisition date.  The Company expects Goodwill to be deductible for tax purposes.

AVINTIV Inc.

In October 2015, the Company acquired 100% of the capital stock of AVINTIV Inc. ("Avintiv") for a purchase price of $2.26 billion, net of cash acquired.  Avintiv is one of the world's leading developers, producers, and marketers of nonwoven specialty materials used in hygiene, infection prevention, personal care, industrial, construction, and filtration applications.  To finance the purchase, the Company issued $400 million aggregate principal amount of 6.0% second priority senior secured notes due 2022 and entered into an incremental assumption agreement to increase the commitments under the Company's existing term loan credit agreement by $2.1 billion due 2022.  The results of Avintiv have been included in the consolidated results of the Company since the date of acquisition.

4.  Restructuring and Impairment Charges

The Company incurred restructuring costs related to severance, asset impairment, and facility exit costs.  The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended				Three Quarterly Periods Ended
	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Consumer Packaging	$	2	$	2	$	6	$	7
Health, Hygiene & Specialties		4		4		8		20
Engineered Materials		2		—		4		2
Consolidated	$	8	$	6	$	18	$	29

8

The table below sets forth the activity with respect to the restructuring accrual at July 1, 2017:

	Severance and termination benefits			Facilities exit costs and other			Total
Balance at October 1, 2016	$	7		$	6		$	13
Charges		14			4			18
Cash payments		(15	)		(6	)		(21	)
Balance at July 1, 2017	$	6		$	4		$	10

5. Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	July 1, 2017		October 1, 2016
Employee compensation, payroll and other	$	128	$	152
Interest		33		53
Rebates		54		54
Restructuring		10		13
Accrued taxes		77		40
Tax receivable agreement obligation		101		60
Accrued operating expenses		95		77
	$	498	$	449

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	July 1, 2017		October 1, 2016
Lease retirement obligation	$	36	$	34
Sale-lease back deferred gain		24		26
Pension liability		82		88
Deferred purchase price		43		41
Tax receivable agreement obligation		22		114
Interest rate swaps		35		45
Other		69		69
	$	311	$	417

The Company made $60 million of payments related to the income tax receivable agreement ("TRA") in the December 31, 2016 quarter, of which Apollo Global Management, LLC received $48 million. The TRA provides for an annual payment to TRA holders equal to 85% of the amount of cash savings, if any, in U.S. federal, foreign, state and local income tax that are actually realized as a result of the utilization of our net operating losses attributable to periods prior to the initial public offering.

6. Long-Term Debt

Long-term debt consists of the following:

	Maturity Date		July 1, 2017			October 1, 2016
Term loan	February 2020	$	1,148		$	1,351
Term loan	January 2021		814			814
Term loan	October 2022		1,695			1,895
Term loan	January 2024		499			—
Revolving line of credit	May 2020		50			—
5 1/8% Second Priority Senior Secured Notes	July 2023		700			700
5 1/2% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
Debt discounts and deferred fees			(52	)		(58	)
Capital leases and other	Various		137			153
Total long-term debt			5,891			5,755
Current portion of long-term debt			(34	)		(43	)
Long-term debt, less current portion		$	5,857		$	5,712

The Company was in compliance with all covenants for all periods presented.

Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense through maturity.

9

Term Loans

In January 2017, the Company entered into an incremental assumption agreement to increase the commitments under the existing term loan credit agreement by $500 million in order to finance the AEP acquisition.  The incremental assumption agreement provided for the $500 million incremental term loan to bear interest at LIBOR plus 2.50% per annum with no LIBOR floor, to mature in January 2024 and to be subject to customary amortization.  During the March ending quarter the Company executed an amendment to lower the interest rates under certain of the term loans.  The term loans maturing in October 2022 bear interest at LIBOR plus 2.50% with no LIBOR floor.  The term loans maturing in February 2020 and January 2021 bear interest at LIBOR plus 2.25% with no LIBOR floor.

During fiscal 2017, the Company has made $427 million of repayments on long-term borrowings using existing liquidity.  As a result of the current year prepayments and modifications, the Company recorded a $3 million loss on debt extinguishment in Other (income) expense, net, reflecting the write-off of deferred financing fees and debt discounts, net of amortization associated with the portion of the debt that was considered extinguished.  Additionally, the Company recognized $9 million of debt discounts and deferred financing fees related to the incremental assumption agreements and amendments.

7. Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors.  The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies.  These financial instruments are not used for trading or other speculative purposes. 

The Company designates derivative instruments that qualify as hedging instruments, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.  To the extent hedging relationships are found to be effective, which is evaluated quarterly, changes in the fair value of the derivatives are offset by changes in the fair value of the related hedged item and recorded to Accumulated other comprehensive loss. 

The Company records the changes in the fair value of derivatives that are not designated as hedging instruments to the Consolidated Statements of Income.

Foreign Currency Forward Contracts

The primary purpose of the Company's foreign currency hedging activities is to manage the potential changes in value associated with the changes in foreign currencies on future foreign cash movements for certain jurisdictions.  The changes in fair value of these derivative contracts are recognized in Other (income) expense, net on the Consolidated Statements of Income and are largely offset by the remeasurement of the underlying intercompany loan.  When valuing foreign currency forward contracts the Company utilizes Level 2 (significant observable inputs) fair value measurements.  These contracts are typically entered into and settled within the given quarterly reporting period.

Interest Rate Swaps - Cash Flow Hedges

The primary purpose of our interest rate swaps is to manage cash flow variability associated with our outstanding variable rate term loan debt.  At inception these contracts are designed as effective cash flow hedges.  When valuing interest rate swaps we utilize derivative Level 2 (significant observable inputs) fair value measurements.  For interest rate swaps that are designated and qualify as cash flow hedges, the effective portion of the gain or loss is reported as a component of Accumulated other comprehensive loss.

Cash flow hedge accounting is discontinued when it is determined that an interest rate swap no longer qualifies as an effective hedge.  When cash flow hedge accounting is de-designated, the swap is subject to the mark-to-market method of accounting prospectively.  Changes in the mark-to-market fair value of the de-designated instrument are recorded to the Consolidated Statements of Income. Unrealized gains and losses that were previously deferred in Accumulated other comprehensive loss are amortized to Interest expense over the remaining term of the swap.

Interest Rate Swap Arrangements

In February 2013, the Company entered into a $1 billion interest rate swap transaction with an effective date of May 2016 and expiration in May 2019.  In June 2013, the Company elected to settle this derivative instrument and received $16 million as a result of this settlement.  The offset is included in Accumulated other comprehensive loss and is being amortized to Interest expense from May 2016 through May 2019, the original term of the swap agreement.

10

In March 2014, the Company entered into a $1 billion interest rate swap transaction with an effective date of February 2016 and expiration in February 2019.  In February 2017, in conjunction with the term loan modifications, the Company discontinued hedge accounting.  Previously unrealized losses in Accumulated other comprehensive loss were being amortized to Interest expense through February 2019, the original term of the swap.  In order to offset the impact of future fair value changes of the March 2014 de-designated swap, the Company entered into a mirrored offsetting swap in February 2017 and has not designated it as a hedge.

In September 2015, the Company entered into a $1 billion interest rate swap transaction with an effective date of December 2015 and expiration in June 2019.  In February 2017, in conjunction with the term loan modifications, the Company entered into an agreement to modify the terms of the original swap on a prospective basis.  At that time, the Company de-designated the hedge and has re-designated the modified swap as an effective cash flow hedge.  The amount included in Accumulated other comprehensive loss at the date of de-designation is being amortized to Interest expense through June 2019, the original term of the swap.  The modified agreement swaps a one-month variable LIBOR contract for a fixed annual rate of 1.5190% with an effective date in March 2017 and expiration in June 2019.

In January 2017, the Company entered into a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.00%, with an effective date in May 2017 and expiration in May 2022.  

In February 2017, the Company entered into a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.3785% with an effective date in February 2017 and expiration in February 2019.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances as of the current period are as follows;

Derivatives Instruments	Hedge Designation	Balance Sheet Location	July 1, 2017		October 1, 2016
Foreign currency forward contracts	Not designated	Other assets	$	3	$	3
Interest rate swaps	Not designated	Other assets		17		—
Interest rate swaps	Designated	Other long-term liabilities		18		35
Interest rate swaps	Not designated	Other long-term liabilities		17		—

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended						Three Quarterly Periods Ended
Derivatives instruments	Statements of Income Location	July 1, 2017			July 2, 2016			July 1, 2017			July 2, 2016
Interest rate swaps	Interest expense, net		$	5		$	6		$	15		$	10
Foreign currency forward contracts	Other (income) expense, net		$	1		$	3		$	—		$	9

The amortization related to unrealized losses in Accumulated other comprehensive loss is expected to be $2 million in the next 12 months.

Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present.  The assets are adjusted to fair value only when the carrying values exceed the fair values.  The categorization of the framework used to price the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value.  These assets include primarily our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant, and equipment.  The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year, and more frequently if impairment indicators exist.  The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2016 assessment.  No impairment indicators were identified in the current quarter.

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of July 1, 2017 and October 1, 2016, along with the impairment loss recognized on the fair value measurement during the period:

	As of July 1, 2017
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,782		2,782		—
Definite lived intangible assets		—		—		1,066		1,066		—
Property, plant, and equipment		—		—		2,375		2,375		—
Total	$	—	$	—	$	6,471	$	6,471	$	—

11

	As of October 1, 2016
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,406		2,406		—
Definite lived intangible assets		—		—		952		952		—
Property, plant, and equipment		—		—		2,224		2,224		3
Total	$	—	$	—	$	5,830	$	5,830	$	3

The Company's financial instruments consist primarily of cash and cash equivalents and long-term debt.  The fair value of our marketable long-term indebtedness exceeded book value by $76 million as of July 1, 2017.  The Company's long-term debt fair values were determined using Level 2 inputs as other significant observable inputs were not available.  

8.  Income Taxes

The Company's effective tax rate was 26% for the quarterly period and three quarterly periods ended July 1, 2017.  Within the quarter, the effective tax rate was favorably impacted by 9% from the discrete item related to share based compensation excess tax benefit.  Our year-to-date effective tax rate of 26% was favorably impacted by 9% from the discrete item related to share based compensation excess tax benefit and a 3% state valuation allowance release, partially offset by a negative impact of 2% due to state taxes and a 2% foreign valuation allowance.

9.    Operating Segments

The Company's operations are organized into three operating segments: Consumer Packaging, Health, Hygiene & Specialties, and Engineered Materials.  The structure is designed to align us with our customers, provide improved service, and drive future growth in a cost efficient manner.  In October 2016, the Company realigned portions of our operating segments in order to leverage geographic management teams and commercial activities.  The international portion of our Retail & Industrial product line was moved from Engineered Materials to the Specialties product line within Health, Hygiene & Specialties, resulting in a $39 million and $108 million movement in Net sales in the quarterly and three quarterly periods ended July 2, 2016, respectively.  Additionally, to align the newly acquired AEP business with our existing Core Films business, $73 million and $230 million of Net sales were moved from Consumer Packaging to Engineered Materials in the quarterly and three quarterly periods ended July 2, 2016, respectively.  As result of these organizational realignments, we have recast prior period segment amounts.  Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended				Three Quarterly Periods Ended
	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Net sales:
Consumer Packaging	$	614	$	631	$	1,752	$	1,845
Health, Hygiene & Specialties		606		606		1,773		1,807
Engineered Materials		686		408		1,689		1,219
Total net sales	$	1,906	$	1,645	$	5,214	$	4,871
Operating income:
Consumer Packaging	$	60	$	58	$	150	$	156
Health, Hygiene & Specialties		53		69		164		140
Engineered Materials		99		52		219		134
Total operating income	$	212	$	179	$	533	$	430
Depreciation and amortization:
Consumer Packaging	$	56	$	61	$	174	$	183
Health, Hygiene & Specialties		46		38		136		143
Engineered Materials		30		21		73		64
Total depreciation and amortization	$	132	$	120	$	383	$	390

	July 1, 2017		October 1, 2016
Total assets:
Consumer Packaging	$	3,268	$	3,315
Health, Hygiene & Specialties		3,441		3,504
Engineered Materials		1,836		834
Total assets	$	8,545	$	7,653

12

Selected information by geography is presented in the following tables:

	Quarterly Period Ended						Three Quarterly Periods Ended
	July 1, 2017			July 2, 2016			July 1, 2017			July 2, 2016
Net sales:
North America		$	1,591		$	1,329		$	4,289		$	3,939
South America			85			88			246			247
Europe			165			166			482			505
Asia			65			62			197			180
Total net sales		$	1,906		$	1,645		$	5,214		$	4,871

	July 1, 2017		October 1, 2016
Long-lived assets:
North America	$	5,420	$	4,724
South America		360		386
Europe		459		462
Asia		284		289
Total Long-lived assets	$	6,523	$	5,861

Selected information by product line is presented in the following tables:

	Quarterly Period Ended					Three Quarterly Periods Ended
(in percentages)	July 1, 2017		July 2, 2016			July 1, 2017	July 2, 2016
Net sales:
Rigid Open Top		44%			43%	42%	42%
Rigid Closed Top		56			57	58	58
Consumer Packaging		100%			100%	100%	100%
Health		22%		21%		22%	20%
Hygiene		44		45		44	45
Specialties		34		34		34	35
Health, Hygiene & Specialties		100%		100%		100%	100%
Core Films		43%			72%	51%	71%
Retail & Industrial		57			28	49	29
Engineered Materials		100%			100%	100%	100%

Goodwill  

In connection with the change in reporting segments, the Company reallocated goodwill to the segments under the provisions of ASC 350.  The changes in the carrying amount of goodwill by reportable segment are as follows:  

	Consumer Packaging			Health, Hygiene & Specialties		Engineered Materials		Total
Balance as of October 1, 2016	$	1,520		$	801	$	85	$	2,406
Segment reorganization		(110	)		7		103		—
Acquisition, net		—			—		376		376
Foreign currency translation adjustment		—			—		—		—
Balance as of July 1, 2017	$	1,410		$	808	$	564	$	2,782

10.  Contingencies and Commitments

The Company is party to various legal proceedings involving routine claims which are incidental to its business.  Although the Company's legal and financial liability with respect to such proceedings cannot be estimated with certainty, management believes that any ultimate liability would not be material to its financial statements.

The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

13

11.  Basic and Diluted Net Income per Share

Basic net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents.  Diluted net income per share is computed by dividing the net income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method and the if-converted method.  For purposes of this calculation, stock options are considered to be common stock equivalents and are only included in the calculation of diluted net income per share when their effect is dilutive.  There were no shares excluded from the calculations as the effect of their conversion into shares of our common stock would be antidilutive.

The following tables and discussion provide a reconciliation of the numerator and denominator of the basic and diluted net income per share computations.

	Quarterly Period Ended				Three Quarterly Periods Ended
(in millions, except per share amounts)	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Numerator
Net income	$	107	$	96	$	230	$	159
Denominator
Weighted average common shares outstanding - basic		129.9		121.1		126.6		120.5
Dilutive shares		5.3		4.8		4.8		3.4
Weighted average common and common equivalent shares outstanding - diluted		135.2		125.9		131.4		123.9
Per common share income
Basic	$	0.82	$	0.79	$	1.82	$	1.32
Diluted	$	0.79	$	0.76	$	1.75	$	1.28

12. Accumulated Other Comprehensive Income (Loss)

The components and activity of Accumulated other comprehensive income (loss) are as follows: 

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps Designated as Hedges			Interest Rate Swaps Not Designated as Hedges			Accumulated Other Comprehensive Income (Loss)
Balance at October 1, 2016	$	(82	)	$	(44	)	$	(31	)	$	9		$	(148	)
De-designated hedges		—			—			17			(17	)		—
Other comprehensive income (loss) before reclassifications		4			13			5			—			22
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			17			1			18
Provision for income taxes related to other comprehensive income items		—			—			(8	)		—			(8	)
Balance at July 1, 2017	$	(78	)	$	(31	)	$	—		$	(7	)	$	(116	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps Designated as Hedges			Interest Rate Swaps Not Designated as Hedges		Accumulated Other Comprehensive Income (Loss)
Balance at September 26, 2015	$	(81	)	$	(25	)	$	(23	)	$	10	$	(119	)
Other comprehensive income (loss) before reclassifications		39			—			(30	)		—		9
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			10			—		10
Provision for income taxes related to other comprehensive income items		—			—			8			—		8
Balance at July 2, 2016	$	(42	)	$	(25	)	$	(35	)	$	10	$	(92	)

14

13.  Guarantor and Non-Guarantor Financial Information

Berry Global, Inc. ("Issuer") has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this Note, "Parent") and substantially all of Issuer's domestic subsidiaries.  Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis.  A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances:  the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture, as a result of the holders of certain other indebtedness foreclosing on a pledge of the shares of a guarantor subsidiary or if such guarantor no longer guarantees certain other indebtedness of the issuer.  The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company's debts.  Parent also guarantees the Issuer's term loans and revolving credit facilities.  The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility.  Presented below is condensed consolidating financial information for the Parent, Issuer, guarantor subsidiaries and non-guarantor subsidiaries.  The Issuer and guarantor financial information includes all of our domestic operating subsidiaries; our non-guarantor subsidiaries include our foreign subsidiaries, certain immaterial domestic subsidiaries and the unrestricted subsidiaries under the Issuer's indentures.  The Parent uses the equity method to account for its ownership in the Issuer in the Condensed Consolidating Supplemental Financial Statements.  The Issuer uses the equity method to account for its ownership in the guarantor and non-guarantor subsidiaries.  All consolidating entries are included in the eliminations column along with the elimination of intercompany balances.

Condensed Supplemental Consolidated Balance Sheet

	July 1, 2017
	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	80	$	1,188	$	754	$	—		$	2,022
Intercompany receivable		518		2,512		—		—		(3,030	)		—
Property, plant, and equipment, net		—		74		1,591		710		—			2,375
Other assets		868		5,217		4,578		523		(7,038	)		4,148
Total assets	$	1,386	$	7,883	$	7,357	$	1,987	$	(10,068	)	$	8,545
Current liabilities	$	101	$	167	$	563	$	282	$	—		$	1,113
Intercompany payable		—		66		2,819		145		(3,030	)		—
Other long-term liabilities		437		5,976		105		66		—			6,584
Stockholders' equity (deficit)		848		1,674		3,870		1,494		(7,038	)		848
Total liabilities and stockholders' equity	$	1,386	$	7,883	$	7,357	$	1,987	$	(10,068	)	$	8,545

	October 1, 2016
	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	161	$	945	$	686	$	—		$	1,792
Intercompany receivable		364		2,797		—		—		(3,161	)		—
Property, plant and equipment, net		—		76		1,434		714		—			2,224
Other assets		302		4,101		4,094		557		(5,417	)		3,637
Total assets	$	666	$	7,135	$	6,473	$	1,957	$	(8,578	)	$	7,653
Current liabilities	$	60	$	207	$	480	$	284	$	—		$	1,031
Intercompany payable		—		—		2,992		169		(3,161	)		—
Other long-term liabilities		385		5,822		126		68		—			6,401
Stockholders' equity (deficit)		221		1,106		2,875		1,436		(5,417	)		221
Total liabilities and stockholders' equity	$	666	$	7,135	$	6,473	$	1,957	$	(8,578	)	$	7,653

15

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended July 1, 2017
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	152		$	1,325		$	429		$	—		$	1,906
Cost of goods sold		—			100			1,059			359			—			1,518
Selling, general and administrative		—			14			89			25			—			128
Amortization of intangibles		—			2			31			7			—			40
Restructuring and impairment charges		—			—			—			8			—			8
Operating income		—			36			146			30			—			212
Other expense (income), net		—			1			(1	)		(1	)		—			(1	)
Interest expense, net		—			5			47			16			—			68
Equity in net income of subsidiaries		(145	)		(109	)		—			—			254			—
Income before income taxes		145			139			100			15			(254	)		145
Income tax expense		38			32			—			6			(38	)		38
Net income	$	107		$	107		$	100		$	9		$	(216	)	$	107
Comprehensive net income	$	107		$	102		$	100		$	37		$	(216	)	$	130

	Quarterly Period Ended July 2, 2016
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	150		$	1,081		$	414		$	—		$	1,645
Cost of goods sold		—			140			834			322			—			1,296
Selling, general and administrative		—			6			93			30			—			129
Amortization of intangibles		—			2			27			6			—			35
Restructuring and impairment charges		—			—			1			5			—			6
Operating income		—			2			126			51			—			179
Other expense (income), net		—			8			(4	)		(18	)		—			(14	)
Interest expense, net		—			9			63			1			—			73
Equity in net income of subsidiaries		(120	)		(119	)		—			—			239			—
Income before income taxes		120			104			67			68			(239	)		120
Income tax expense		24			4			1			14			(19	)		24
Net income	$	96		$	100		$	66		$	54		$	(220	)	$	96
Comprehensive net income	$	96		$	98		$	65		$	38		$	(220	)	$	77

	Three Quarterly Periods Ended July 1, 2017
	Parent			Issuer			Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	441		$	3,556	$	1,217	$	—		$	5,214
Cost of goods sold		—			333			2,860		984		—			4,177
Selling, general and administrative		—			45			251		77		—			373
Amortization of intangibles		—			5			87		21		—			113
Restructuring and impairment charges		—			—			10		8		—			18
Operating income		—			58			348		127		—			533
Other expense (income), net		—			15			1		2		—			18
Interest expense, net		—			17			138		48		—			203
Equity in net income of subsidiaries		(312	)		(252	)		—		—		564			—
Income before income taxes		312			278			209		77		(564	)		312
Income tax expense		82			48			—		34		(82	)		82
Net income	$	230		$	230		$	209	$	43	$	(482	)	$	230
Comprehensive net income	$	230		$	245		$	209	$	60	$	(482	)	$	262

16

Consolidating Statement of Cash Flows
Cash Flow from Operating Activities	$	—		$	31		$	420		$	129		$	—		$	580
Cash Flow from Investing Activities
Additions to  property, plant, and equipment		—			(11	)		(160	)		(30	)		—			(201	)
Proceeds from sale of assets		—			1			3			—			—			4
Contributions (to)/from subsidiaries		(26	)		(489	)		—			—			515			—
Intercompany		—			280			—			—			(280	)		—
Acquisition of business, net of cash acquired		—			—			(515	)		—			—			(515	)
Other investing activities, net		—			(1	)		—			—			—			(1	)
Net cash from investing activities		(26	)		(220	)		(672	)		(30	)		235			(713	)
Cash Flow from Financing Activities
Proceeds from long-term debt		—			545			—			—			—			545
Proceeds from issuance of common stock		26			—			—			—			—			26
Payment of tax receivable agreement		(60	)		—			—			—			—			(60	)
Repayments on long-term borrowings		—			(423	)		(3	)		(1	)		—			(427	)
Contribution from Parent		—			—			515			—			(515	)		—
Debt financing costs		—			(4	)		—			—			—			(4	)
Changes in intercompany balances		60			—			(255	)		(85	)		280			—
Net cash from financing activities		26			118			257			(86	)		(235	)		80
Effect of exchange rate changes on cash		—			—			—			5			—			5
Net change in cash		—			(71	)		5			18			—			(48	)
Cash and cash equivalents at beginning of period		—			102			5			216			—			323
Cash and cash equivalents at end of period	$	—		$	31		$	10		$	234		$	—		$	275

	Three Quarterly Periods Ended July 2, 2016
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	442		$	3,143		$	1,286		$	—		$	4,871
Cost of goods sold		—			373			2,490			1,022			—			3,885
Selling, general and administrative		—			89			251			81			—			421
Amortization of intangibles		—			6			77			23			—			106
Restructuring and impairment charges		—			—			23			6			—			29
Operating income		—			(26	)		302			154			—			430
Other expense (income), net		—			19			(11	)		(25	)		—			(17	)
Interest expense, net		—			27			158			37			—			222
Equity in net income of subsidiaries		(225	)		(258	)		—			—			483			—
Income before income taxes		225			186			155			142			(483	)		225
Income tax expense		66			23			2			36			(61	)		66
Net income	$	159		$	163		$	153		$	106		$	(422	)	$	159
Comprehensive net income	$	159		$	152		$	152		$	145		$	(422	)	$	186

17

Consolidating Statement of Cash Flows
Cash Flow from Operating Activities	$	—		$	23		$	382		$	162		$	—		$	567
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(13	)		(181	)		(34	)		—			(228	)
Proceeds from sale of assets		—			—			4			—			—			4
Contributions (to)/from subsidiaries		(20	)		(2,240	)		—			—			2,260			—
Intercompany		—			11			—			—			(11	)		—
Acquisition of business, net of cash acquired		—			—			(291	)		(1,992	)		—			(2,283	)
Other investing activities, net		—			(11	)		—			—			—			(11	)
Net cash from investing activities		(20	)		(2,253	)		(468	)		(2,026	)		2,249			(2,518	)
Cash Flow from Financing Activities
Proceeds from long-term debt		—			2,490			—			—			—			2,490
Repayments on long-term borrowings		—			(356	)		—			(34	)		—			(390	)
Proceeds from issuance of common stock		20			—			—			—			—			20
Payment of tax receivable agreement		(57	)		—			—			—			—			(57	)
Contribution from parent		—			—			291			1,969			(2,260	)		—
Debt financing costs		—			(38	)		—			—			—			(38	)
Purchase of non-controlling interest		—			—			(66	)		—			—			(66	)
Changes in intercompany balances		57			—			(110	)		42			11			—
Net cash from financing activities		20			2,096			115			1,977			(2,249	)		1,959
Effect of exchange rate changes on cash		—			—			—			—			—			—
Net change in cash		—			(134	)		29			113			—			8
Cash and cash equivalents at beginning of period		—			163			—			65			—			228
Cash and cash equivalents at end of period	$	—		$	29		$	29		$	178		$	—		$	236

18

Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations

This discussion contains forward-looking statements and involves numerous risks and uncertainties, including, but not limited to, those described in our most recent Form 10-K in the section titled "Risk Factors" and other risk factors identified from time to time in our periodic filings with the SEC.  As a result, our actual results may differ materially from those contained in any forward-looking statements.  The forward-looking statements referenced within this report should be read with the explanation of the qualifications and limitations included herein.

The Company's fiscal year is based on fifty-two or fifty-three week periods.  Fiscal 2017 is a fifty-two week period and fiscal 2016 was a fifty-three week period.

Executive Summary

Business.  The Company's operations are organized into three operating segments: Engineered Materials, Health, Hygiene & Specialties, and Consumer Packaging.  The structure is designed to align us with our customers, provide improved service, and drive future growth in a cost efficient manner.  The Engineered Materials segment primarily consists of tapes and adhesives, polyethylene based film products, can liners, printed films, and specialty coated, and laminated products.  The Health, Hygiene & Specialties segment primarily consists of nonwoven specialty materials and films used in hygiene, infection prevention, personal care, industrial, construction and filtration applications.  The Consumer Packaging segment primarily consists of containers, foodservice items, closures, overcaps, bottles, prescription containers, and tubes. 

In October 2016, the Company realigned portions of our operating segments in order to leverage geographic management teams and commercial activities.  The international portion of our Retail & Industrial product line was moved from Engineered Materials to the Specialties product line within Health, Hygiene & Specialties, resulting in a $39 million and $108 million movement in Net sales in the quarterly and three quarterly periods ended July 2, 2016, respectively.  Additionally, to align the newly acquired AEP business with our existing Core Films business, $73 million and $230 million of Net sales were moved from Consumer Packaging to Engineered Materials in the quarterly and three quarterly periods ended July 2, 2016, respectively.  As result of these organizational realignments, we have recast prior period segment amounts.

Acquisitions. Our acquisition strategy is focused on improving our long-term financial performance, enhancing our market positions, and expanding our existing and complementary product offerings.  We seek to acquire businesses for attractive post-synergy multiples, creating value for our stockholders from synergy realization, leveraging the acquired products across our customer base, creating new platforms for future growth, and assuming best practices from the businesses we acquire.  The Company has included the expected benefits of acquisition integrations and restructuring plans within our unrealized synergies, which are in turn recognized in earnings after an acquisition has been fully integrated or the restructuring plan is completed.  While the expected benefits on earnings is estimated at the commencement of each transaction, once the execution of the plan and integration occur, we are generally unable to accurately estimate or track what the ultimate effects have been due to system integrations and movements of activities to multiple facilities.  As historical business combinations and restructuring plans have not allowed us to accurately separate realized synergies compared to what was initially identified, we measure the synergy realization based on the overall segment profitability post integration.

Avintiv Inc.

In October 2015, the Company acquired 100% of the capital stock of AVINTIV Inc. ("Avintiv") for a purchase price of $2.26 billion, net of cash acquired.  Avintiv is one of the world's leading developers, producers, and marketers of nonwoven specialty materials used in hygiene, infection prevention, personal care, industrial, construction, and filtration applications.  To finance the purchase, the Company issued $400 million aggregate principal amount of 6.0% second priority senior secured notes due 2022 and entered into an incremental assumption agreement to increase the commitments under the Company's existing term loan credit agreement by $2.1 billion due 2022.  The Company expects to realize annual cost synergies of approximately $80 million related to the Avintiv acquisition with full realization expected in fiscal 2017.

AEP Industries Inc.

In January 2017, the Company acquired AEP Industries Inc. ("AEP") for a purchase price of $791 million, net of cash acquired.  A portion of the purchase price consisted of issuing 6.4 million of Berry common shares which were valued at $324 million at the time of closing.  AEP manufactures and markets an extensive and diverse line of polyethylene and polyvinyl chloride flexible plastic packaging products for consumer, industrial, and agricultural applications.  The acquired business is operated in Berry's Engineered Materials segment.  To finance the purchase, the Company entered into an incremental assumption agreement to increase the commitments under the Company's existing term loan credit agreement by $500 million due 2024.  The Company expects to realize annual cost synergies of approximately $80 million from the AEP transaction with full realization expected in fiscal 2018.

19

Adchem Corp.

In June, 2017, the Company acquired Adchem Corp.'s ("Adchem") tapes business for a purchase price of $49 million.  Adchem is a leader in the development of high performance adhesive tape systems for the automotive, construction, electronics, graphic arts, medical and general tape markets.  The acquired business will be operated within the Engineered Materials segment.  To finance the purchase, the Company used existing liquidity.

Raw Material Trends. Our primary raw material is plastic resin consisting primarily of polypropylene and polyethylene.  Plastic resins are subject to price fluctuations, including those arising from supply shortages and changes in the prices of natural gas, crude oil and other petrochemical intermediates from which resins are produced.  The three month simple average price per pound, as published by U.S. market indexes, were as follows:

	Polyethylene Butene Film						Polypropylene
	2017		2016		2015		2017		2016		2015
1st quarter	$	.75	$	.69	$	.86	$	.69	$	.70	$	.92
2nd quarter		.77		.66		.75		.80		.75		.73
3rd quarter		.79		.73		.76		.74		.71		.68
4th quarter		—		.75		.73		—		.71		.66

Due to differences in the timing of passing through resin cost changes to our customers on escalator/de-escalator programs, segments are negatively impacted in the short term when plastic resin costs increase and are positively impacted when plastic resin costs decrease.  This timing lag in passing through raw material cost changes could affect our results as plastic resin costs fluctuate. 

Outlook.  The Company is impacted by general economic and industrial growth, plastic resin availability and affordability, and general industrial production.  Our business has both geographic and end-market diversity, which reduces the effect of any one of these factors on our overall performance.  Our results are affected by our ability to pass through raw material cost changes to our customers, improve manufacturing productivity and adapt to volume changes of our customers.  We continue to believe the fiscal 2017 volume environment in the markets we serve will remain consistent with prior year and will be impacted by one less week of operations in fiscal 2017 compared to fiscal 2016.  In the near term, inflation and market pressure in South America could temporarily create a headwind for the Company, which we believe will ultimately be offset within the fiscal year by maximizing the synergies from the AEP acquisition.  For fiscal 2017, we project cash flow from operations and Adjusted Free Cash Flow of $925 million and $550 million, respectively.  These estimates assume $80 million of tax payments, $60 million of business integration costs, and no impact to working capital.  The $550 million of Adjusted Free Cash Flow includes $265 million of additions to property, plant and equipment and $110 million of payments under our tax receivable agreement ("TRA").  The $110 million of TRA payments includes $60 million that was paid in our first fiscal quarter and assume we make an additional $50 million in our fourth fiscal quarter.  For the definition of Adjusted Free Cash Flow and further information related to Adjusted Free Cash Flow as a non-GAAP financial measure, see "Liquidity and Capital Resources."

Results of Operations

Comparison of the Quarterly Period Ended July 1, 2017 (the "Quarter") and the Quarterly Period Ended July 2, 2016 (the "Prior Quarter")

Consistent with historical presentation, acquisition (businesses acquired in the last twelve months) net sales and operating income disclosed within this section represent the historical results from acquisitions for the comparable prior year period.  The remaining change disclosed represents the changes from the prior period on a combined basis.  Business integration expenses consist of restructuring and impairment charges, acquisition related charges, and other business optimization costs.

Consolidated Overview
	Quarter				Prior Quarter				$ Change			% Change
Net sales		$	1,906			$	1,645			$	261		16	%
Operating income		$	212			$	179			$	33		18	%
Operating income percentage of net sales			11	%			11	%

Net sales increased by $261 million from the Prior Quarter primarily attributed to acquisition net sales of $296 million and selling price increases of $49 million due to the pass through of higher resin prices, partially offset by a negative $76 million impact from lower base volumes and an $8 million negative impact from foreign currency changes.  The base volume decline is primarily related to general market softness along with inventory reductions by our Engineered Materials customers in anticipation of lower future raw material costs, as well as our decisions between volume and price in order to maximize earnings.

20

The operating income increase of $33 million from the Prior Quarter was primarily attributed to acquisition operating income of $22 million, a $14 million decrease in selling, general and administrative expense, an $11 million improvement in our product mix and price/cost spread, and a decrease in business integration expenses.  These improvements were partially offset by a $5 million increase in depreciation and amortization, and a negative $12 million impact from lower base volumes.

Consumer Packaging
	Quarter				Prior Quarter				$ Change				% Change
Net sales		$	614			$	631			$	(17	)		(3	%)
Operating income		$	60			$	58			$	2			3	%
Percentage of net sales			10	%			9	%

Net sales in the Consumer Packaging segment decreased by $17 million from Prior Quarter primarily attributed to a negative $25 million impact from lower base volumes, primarily attributed to general market softness.  The decrease is partially offset by an $8 million selling price increase due to the pass through of higher resin prices.

The operating income increase of $2 million from Prior Quarter was primarily attributed to a $5 million decrease in selling, general and administrative expense and a $5 million decrease in depreciation and amortization.  These improvements were partially offset by a negative $5 million impact from lower base volumes, and a slight impact from negative productivity in manufacturing.

Health, Hygiene & Specialties
	Quarter				Prior Quarter				$ Change				% Change
Net sales		$	606			$	606			$	—			0	%
Operating income		$	53			$	69			$	(16	)		(23	%)
Percentage of net sales			9	%			11	%

Net sales in the Health, Hygiene & Specialties segment were flat from Prior Quarter primarily attributed to selling price increases of $8 million due to the pass through of higher resin prices, partially offset by a $7 million unfavorable impact from currency translation.

The operating income decrease of $16 million from Prior Quarter was primarily attributed to a $15 million decrease in price/cost spread and an $8 million increase in depreciation and amortization expense as a result of Avintiv purchase accounting adjustments recorded in the Prior Quarter, partially offset by a $4 million decrease in selling, general, and administrative expense, and a slight improvement in productivity in manufacturing.

Engineered Materials
	Quarter				Prior Quarter				$ Change			% Change
Net sales		$	686			$	408			$	278		68	%
Operating income		$	99			$	52			$	47		90	%
Percentage of net sales			14	%			13	%

Net sales in the Engineered Materials segment increased by $278 million from Prior Quarter primarily attributed to acquisition net sales of $296 million and selling price increases of $32 million due to the pass through of higher resin prices, partially offset by a negative $49 million impact from lower base volumes.  We believe the volume decline is partially attributed to inventory reductions by our customers in anticipation of lower future resin costs, as well as our decisions between volume and price in order to maximize earnings.

The operating income increase of $47 million from Prior Quarter was primarily attributed to acquisition operating income of $22 million, a $25 million improvement in our product mix and price/cost spread, and a $5 million reduction in selling, general and administrative expenses, partially offset by a negative $7 million impact from lower base volumes.

Other (income) expense, net
	Quarter				Prior Quarter				$ Change			% Change
Other (income) expense, net		$	(1	)		$	(14	)		$	13		93	%

Other (income) expense primarily consists of transactional foreign currency changes related to the remeasurement of non-operating intercompany balances.

Interest expense, net
	Quarter			Prior Quarter			$ Change				% Change
Interest expense, net		$	68		$	73		$	(5	)		(7	%)

21

The interest expense decrease of $5 million from Prior Quarter was primarily attributed to reduced interest rates resulting from the term loan modifications.

Income tax expense
	Quarter			Prior Quarter			$ Change			% Change
Income tax expense		$	38		$	24		$	14		58	%

The income tax expense increase of $14 million from the Prior Quarter was primarily attributed to an increase in Income before taxes and an increase in foreign valuation allowance for the Quarter.  Within the Quarter, the 26% effective tax rate was lower than our statutory rate primarily due to a favorable impact of 9% from the discrete item related to share based compensation excess tax benefit.

Changes in Comprehensive Income

The $53 million improvement in comprehensive income from Prior Quarter is primarily attributed to a $40 million change in currency translation, an $11 million improvement in net income, and a $2 million change in interest rate hedges, net of tax.  Currency translation gains and losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates.  The change in currency translation in the Quarter was primarily attributed to locations utilizing the euro, British pound sterling, and Brazilian real as the functional currency.  As part of the overall risk management, the Company uses derivative instruments to reduce exposure to changes in interest rates attributed to the Company's floating-rate borrowings and records changes to the fair value of these instruments in Accumulated other comprehensive income (loss).  The favorable change in fair value of these instruments in the Quarter versus Prior Quarter is primarily attributed to an increase in the forward interest curve between measurement dates.

Comparison of the Three Quarterly Periods Ended July 1, 2017 (the "YTD") and the Three Quarterly Periods Ended July 2, 2016 (the "Prior YTD")

As a reminder, fiscal 2016 was a fifty-three week period compared to a fifty-two week period in fiscal 2017.  The negative impact from the extra days in the Prior YTD period disclosed within this section has been presented on a net basis.  Consistent with historical presentation, acquisition (businesses acquired in the last twelve months) net sales and operating income disclosed within this section represent the historical results from acquisitions for the comparable prior year period.  The remaining change disclosed represents the changes from the prior period on a combined basis.  Business integration expenses consist of restructuring and impairment charges, acquisition related charges, and other business optimization costs.

Consolidated Overview
	YTD				Prior YTD				$ Change			% Change
Net sales		$	5,214			$	4,871			$	343		7	%
Operating income		$	533			$	430			$	103		24	%
Operating income percentage of net sales			10	%			9	%

The net sales increase of $343 million from the Prior YTD was primarily attributed to acquisition net sales of $500 million and selling price increases of $52 million due to the pass through of higher resin prices, partially offset by a $98 million negative impact from extra days in the Prior YTD, a $92 million negative impact from lower base volumes, and a negative $20 million impact from foreign currency changes.  The base volume decline is primarily related to general market softness along with inventory reductions by our Engineered Materials customers in anticipation of lower raw material costs, as well as our decisions between volume and price in order to maximize earnings.

The operating income increase of $103 million from the Prior YTD was primarily attributed to acquisition operating income of $42 million, a $33 million decrease in selling, general and administrative expense related to synergies and cost reductions, a $33 million decrease in business integration and restructuring expenses, a $13 million decrease in depreciation and amortization, and a slight improvement in our product mix and price/cost spread.  These improvements were partially offset by a negative $12 million impact from lower base volumes and a negative $10 million impact from extra days in the Prior YTD.

Consumer Packaging
	YTD				Prior YTD				$ Change				% Change
Net sales		$	1,752			$	1,845			$	(93	)		(5	%)
Operating income		$	150			$	156			$	(6	)		(4	%)
Operating income percentage of net sales			9	%			8	%

22

Net sales in the Consumer Packaging segment decreased by $93 million from Prior YTD primarily attributed to a $64 million negative impact from lower base volumes and a negative $43 million impact from extra days in the Prior YTD, partially offset by selling price increases of $14 million due to the pass through of higher resin prices.  The volume decline was primarily attributed to general market softness.

The operating income decrease of $6 million from Prior YTD was primarily attributed to a negative $14 million impact from lower base volumes, a negative $9 million impact from productivity in manufacturing, a negative $5 million impact from extra days in the Prior YTD, and a slight decrease in our product mix and price/cost spread, partially offset by a $13 million decrease in selling, general and administrative expense related to synergies from cost reductions, a $6 million decrease in depreciation and amortization, and a $5 million decrease in business integration and restructuring expenses.

Health, Hygiene & Specialties
	YTD				Prior YTD				$ Change				% Change
Net sales		$	1,773			$	1,807			$	(34	)		(2	%)
Operating income		$	164			$	140			$	24			17	%
Operating income percentage of net sales			9	%			8	%

Net sales in the Health, Hygiene & Specialties segment decreased by $34 million from Prior YTD primarily attributed to selling price decreases of $20 million, a negative $26 million impact from extra days in the Prior YTD, and an $18 million unfavorable impact from currency translation, partially offset by a $30 million impact from base volume improvements.

The operating income increase of $24 million from Prior YTD was primarily attributed to a $29 million decrease in business integration and restructuring expenses, an $11 million improvement in productivity in manufacturing, a $9 million decrease in selling, general and administrative expense related to synergies and cost reductions, a $5 million improvement from base volume growth, and a $4 million decrease in depreciation and amortization.  These improvements were partially offset by a $33 million decrease in our product mix and price/cost spread primarily attributed to inflation and consumer demand pressures within our South American business.

Engineered Materials
	YTD				Prior YTD				$ Change			% Change
Net sales		$	1,689			$	1,219			$	470		39	%
Operating income		$	219			$	134			$	85		63	%
Operating income percentage of net sales			13	%			11	%

Net sales in the Engineered Materials segment increased by $470 million from Prior YTD primarily attributed to acquisition net sales of $500 million, and selling price increases of $57 million due to the pass through of higher resin prices, partially offset by a negative $57 million impact from base volume declines, and a $29 million unfavorable impact from extra days in the Prior YTD.  We believe the volume decline is partially attributed to inventory reductions by our customers in anticipation of lower future resin costs, as well as our decisions between volume and price in order to maximize earnings.

The operating income increase of $85 million in the Engineered Materials segment from the Prior YTD was primarily attributed to acquisition operating income of $42 million, a $37 million improvement in our product mix and price/cost spread, an $11 million decrease in selling, general and administrative expense, and a $4 million decrease in depreciation and amortization.  These improvements were partially offset by a $4 million negative impact from extra days in the Prior YTD and a negative $3 million impact from lower base volumes.

Other (income) expense, net
	YTD			Prior YTD				$ Change			% Change
Other (income) expense, net		$	18		$	(17	)		$	35		206	%

Other (income) expense was unfavorable by $35 million from Prior YTD primarily attributed to a $10 million non-cash defined benefit pension plan settlement and a $9 million charge related to a valuation adjustment to the TRA in the YTD, and unfavorable transactional foreign currency changes related to the remeasurement of non-operating intercompany balances.

Interest expense, net
	YTD			Prior YTD			$ Change				% Change
Interest expense, net		$	203		$	222		$	(19	)		(9	%)

23

The interest expense decrease of $19 million from Prior YTD was primarily attributed to reduced interest rates resulting from term loan modification.

Income tax expense
	YTD			Prior YTD			$ Change			% Change
Income tax expense		$	82		$	66		$	16		24	%

The income tax expense increase of $16 million from the Prior YTD was primarily attributed to an increase in Income before income taxes, partially offset by favorable year-to-date effective tax rate items.  Our year-to-date effective tax rate of 26% was lower than our statutory rate primarily due to a favorable impact of 9% from the share based compensation excess tax benefit and a 3% state valuation allowance release, partially offset by a negative impact of 2% due to state taxes and a 2% foreign valuation allowance.

Changes in Comprehensive Income

The $76 million improvement in comprehensive income from the Prior YTD was primarily attributed to a $71 million improvement in net income, a $27 million change in the fair value of interest rate hedges, net of tax, and a $13 million change due to a non-cash defined benefit pension plan settlement, partially offset by a $35 million change in currency translation.  Currency translation gains and losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates.  The change in currency translation in the YTD was primarily attributed to locations utilizing the euro, British pound sterling, and Brazilian real as the functional currency.  As part of the overall risk management, the Company uses derivative instruments to reduce exposure to changes in interest rates attributed to the Company's floating-rate borrowings and records changes to the fair value of these instruments in Accumulated other comprehensive income (loss).  The favorable change in fair value of these instruments in the YTD versus Prior YTD is primarily attributed to an increase in the forward interest curve between measurement dates.

Liquidity and Capital Resources

As of the end of the quarter, we had cash and cash equivalents of $275 million, of which approximately 87% was located outside of the U.S.  Our primary sources of cash are the collection of trade receivables generated from the sales of our products and services to our customers and amounts available under our existing lines of credit.  Our primary uses of cash are payments for operating expenses, investments in working capital, capital expenditures, interest, taxes, debt obligations, restructuring expenses and other long-term liabilities.  Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings under our senior secured credit facilities, will be adequate to meet our short-term liquidity needs over the next twelve months.  We base such belief on historical experience and the funds available under the revolving credit facility.  However, we cannot predict our future results of operations and our ability to meet our obligations involves numerous risks and uncertainties, including, but not limited to, those described in the "Risk Factors" section of our most recent Form 10-K filed with the SEC.  In particular, increases in the cost of resin which we are unable to pass through to our customers on a timely basis or significant acquisitions could severely impact our liquidity.

Senior Secured Credit Facility

We manage our global cash requirements considering (i) available funds among the many subsidiaries through which we conduct business, (ii) the geographic location of our liquidity needs, and (iii) the cost to access international cash balances.  In March 2017, we entered into an agreement to increase our asset-based revolving line of credit that matures in May 2020 by $100 million to $750 million.  At the end of the Quarter, the Company had $50 million outstanding on the revolving credit facility.  The Company was in compliance with all covenants at the end of the Quarter.

A key financial metric utilized in the calculation of our debt covenants is adjusted EBITDA (defined as "EBITDA" in the Company's debt agreements, but referred herein as Adjusted EBITDA). The following table reconciles (i) our net income to Adjusted EBITDA and (ii) our cash flow from operating activities to Adjusted Free Cash Flow for the four quarters ended July 1, 2017:

	July 1, 2017
	Four Quarters Ended
Net income	$	307
Income tax expense		88
Interest expense, net		272
Other income (expense), net		17
Other non-cash charges (a)		34
Restructuring and impairment		21
Business optimization (b)		21

24

Depreciation and amortization		518
Acquisition Adjusted EBITDA		60
Unrealized cost savings (c)		64
Adjusted EBITDA	$	1,402
Cash flow from operating activities	$	870
Net additions to property, plant and equipment		(256	)
Payments of tax receivable agreement		(60	)
Adjusted Free Cash Flow	$	554
Cash flow from investing activities		(774	)
Cash flow from financing activities		(62	)

(a) Includes stock compensation expense of $19 million and other non-cash charges

(b) Includes business optimization and integration expenses

(c) Consists of unrealized synergies related to acquisitions

Adjusted EBITDA and Adjusted Free Cash Flow, as presented in this document, are supplemental financial measures that are not required by, or presented in accordance with, generally accepted accounting principles in the United States ("GAAP").  Adjusted EBITDA and Adjusted Free Cash Flow are not GAAP financial measures and should not be considered as an alternative to operating income or net income or cash flows from operating activities, in each case determined in accordance with GAAP.  Adjusted EBITDA is used by our lenders for debt covenant compliance.

We define "Adjusted Free Cash Flow" as cash flow from operating activities less additions to property, plant and equipment and payments of the tax receivable agreement.  We believe Adjusted Free Cash Flow is useful to an investor in evaluating our liquidity because Adjusted Free Cash Flow and similar measures are widely used by investors, securities analysts and other interested parties in our industry to measure a company's liquidity.

These non-GAAP financial measures may be calculated differently by other companies, including other companies in our industry, limiting their usefulness as comparative measures.

Tax Receivable Agreement

The Company made $60 million of TRA payments in the first fiscal quarter of 2017.  The Company anticipates making $110 million of TRA payments during fiscal 2017 with the remaining $50 million being paid in the fourth fiscal quarter of 2017.

Cash Flows

Net cash from operating activities increased $13 million from the Prior YTD primarily attributed to improved net income before depreciation, amortization, and other non-cash charges, partially offset by higher working capital due to timing and higher resin costs.

Net cash from investing activities decreased $1,805 million from the Prior YTD primarily attributed to the Avintiv acquisition in the Prior YTD and decreased capital expenditures compared to the Prior YTD, partially offset by the acquisition of AEP and Adchem in the YTD.

Net cash from financing activities decreased $1,879 million from the Prior YTD primarily attributed to the incremental financing and related costs incurred related to the Avintiv acquisition and the Providência tender offer in the Prior YTD, compared to the incremental financing and related costs incurred for the AEP acquisition in the YTD period.

25

Item 3.Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Sensitivity

We are exposed to market risk from changes in interest rates primarily through our senior secured credit facilities.  At July 1, 2017, our senior secured credit facilities are comprised of (i) $4.2 billion term loans and (ii) a $750 million revolving credit facility with $50 million of borrowings outstanding.  Borrowings under our senior secured credit facilities bear interest, at our option, at either (1) an alternate base rate or (2) an adjusted LIBOR rate for a one-, two-, three- or six month interest period, or a nine- or twelve-month period, if available to all relevant lenders, in each case, plus an applicable margin.  The alternate base rate is the greater of (i) in the case of our term loans, Credit Suisse's prime rate or, in the case of our revolving credit facility, Bank of America's prime rate and (ii) one-half of 1.0% over the weighted average of rates on overnight Federal Funds as published by the Federal Reserve Bank of New York.  At July 1, 2017, the LIBOR rate of approximately 1.22% was applicable to the term loans.  A 0.25% change in LIBOR would increase our annual interest expense by $4 million on variable rate term loans.

In February 2013, the Company entered into a $1 billion interest rate swap transaction with an effective date of May 2016 and expiration in May 2019.  In June 2013, the Company elected to settle this derivative instrument and received $16 million as a result of this settlement.  The offset is included in Accumulated other comprehensive loss and is being amortized to Interest expense from May 2016 through May 2019, the original term of the swap agreement.

In March 2014, the Company entered into a $1 billion interest rate swap transaction with an effective date of February 2016 and expiration in February 2019.  In February 2017, in conjunction with the term loan modifications, the Company discontinued hedge accounting.  Previously unrealized losses in Accumulated other comprehensive loss are being amortized to Interest expense through February 2019, the original term of the swap.  In order to offset the impact of future fair value changes of the March 2014 de-designated swap, the Company entered into a mirrored offsetting swap in February 2017 and has not designated it as a hedge.

In September 2015, the Company entered into a $1 billion interest rate swap transaction with an effective date of December 2015 and expiration in June 2019.  In February 2017, in conjunction with the term loan modifications, the Company entered into an agreement to modify the terms of the original swap on a prospective basis.  At this time, the Company de-designated the hedge and has re-designated the modified swap as an effective cash flow hedge.  The amount included in Accumulated other comprehensive loss at the date of de-designation is being amortized to Interest expense through June 2019, the original term of the swap.  The modified agreement swaps a one-month variable LIBOR contract for a fixed annual rate of 1.5190% with an effective date in March 2017 and expiration in June 2019.

In January 2017, the Company entered into a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.00%, with an effective date in May 2017 and expiration in May 2022.  

In February 2017, the Company entered into a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.3785% with an effective date in February 2017 and expiration in February 2019.

Foreign Currency Exchange Rates

As a global company, we face foreign currency risk exposure from fluctuating currency exchange rates, primarily the U.S. dollar against the euro, Brazilian real, British pound sterling, Argentine peso, Chinese yuan, Canadian dollar and Mexican peso.  Significant fluctuations in currency rates can have a substantial impact, either positive or negative, on our revenue, cost of sales, and operating expenses.  As there is uncertainty in the future movements in foreign exchange rates, significant fluctuations could negatively impact our future consolidated results of operations.  Currency translation gains and losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates and impact our Comprehensive income.  While future consolidated results of operations could be materially impacted by fluctuations in currency rates, we attempt to manage our foreign currency risk on our anticipated cash movements by entering into foreign currency forward contracts to offset potential foreign exchange gains or losses.  A 10% change in our foreign currency forward contracts would not result in a material change to our financial statements.

26

Item 4. Controls and Procedures

(a) Evaluation of disclosure controls and procedures.

Under applicable SEC regulations, management of a reporting company, with the participation of the principal executive officer and principal financial officer, must periodically evaluate the company's "disclosure controls and procedures," which are defined generally as controls and other procedures of a reporting company designed to ensure that information required to be disclosed by the reporting company in its periodic reports filed with the commission (such as this Form 10-Q) is recorded, processed, summarized, and reported on a timely basis.

As reported in our 2016 Annual Report on Form 10-K, Berry's management concluded that its internal control over financial reporting and its disclosure controls and procedures were not effective as of October 1, 2016.  This conclusion was specifically impacted by deficiencies in the design and operating effectiveness related to the timeliness of Berry's annual income tax provision process and the adequacy of written documentation around aspects of its foreign tax provisions resulting primarily from the increased complexity in the legal entity structure following the acquisition of Avintiv.  As there were no errors in the accounting or adjustments to the consolidated financial statements as a result of these identified deficiencies, management concluded that there was no impact on Berry's prior or current period consolidated financial statements and that Berry's financial statements were presented fairly in all material respects.  Since October 1, 2016, Berry's management has taken remedial actions, and in that regard, has allocated resources internally that we believe will allow us to accelerate the timing of the completion of foreign tax provisions and increase the level of written documentation related to all aspects of the income tax provision.

The Company's management, with the participation of the Chief Executive Officer and the Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the disclosure controls and procedures as of July 1, 2017.  Because many of the controls in the income tax provision process operate on an annual basis, the assessment of the remediation of the above referenced material weakness will not be fully completed until the Company's fiscal year-end.  As a result, management has concluded that our disclosure controls and procedures were not effective as of the last day of the period covered by this report.

(b) Changes in internal controls.

Except as set forth above, there were no changes in our internal control over financial  reporting that occurred during the quarter ended July 1, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

27

Part II. Other Information

Item 1. Legal Proceedings

There have been no material changes in legal proceedings from the items disclosed in our Form 10-K filed with the Securities and Exchange Commission.

Item 1A. Risk Factors

Before investing in our securities, we recommend that investors carefully consider the risks described in our most recent Form 10-K filed with the SEC, including those under the heading "Risk Factors" and other information contained in this Quarterly Report.  Realization of any of these risks could have a material adverse effect on our business, financial condition, cash flows and results of operations. There were no material changes in the Company's risk factors since described in our most recent Form 10-K filed with the SEC.

All forward-looking information and subsequent written and oral forward-looking statements attributable to us, or to persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements. Some of the factors that we believe could affect our results include: 

● risks associated with our substantial indebtedness and debt service; 

● changes in prices and availability of resin and other raw materials and our ability to pass on changes in raw material prices on a timely basis; 

● performance of our business and future operating results; 

● risks related to our acquisition strategy and integration of acquired businesses; 

● reliance on unpatented know-how and trade secrets; 

● increases in the cost of compliance with laws and regulations, including environmental, safety, and production and product laws and regulations; 

● risks related to disruptions in the overall economy and the financial markets that may adversely impact our business; 

● catastrophic loss of one of our key manufacturing facilities, natural disasters, and other unplanned business interruptions; 

● risks of competition, including foreign competition, in our existing and future markets; 

● risks related to the market acceptance of our developing technologies and products;

● general business and economic conditions, particularly an economic downturn; 

● risks that our restructuring program may entail greater implementation costs or result in lower cost savings than anticipated;

● the ability of our insurance to cover fully our potential exposures; and

● the other factors discussed in our most recent Form 10-K in the section titled "Risk Factors." 

We caution readers that the foregoing list of important factors may not contain all of the material factors that are important to you.  In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this Form 10-Q may not in fact occur.  Accordingly, investors should not place undue reliance on those statements.  We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

28

Item 6.	Exhibits
3.1	Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Berry Plastics Group, Inc. (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K filed on April 18, 2017).
31.1	Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.*
31.2	Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.*
32.1	Section 1350 Certification of the Chief Executive Officer.*
32.2	Section 1350 Certification of the Chief Financial Officer.*
101.	Interactive Data Files.

*  Filed herewith.

29

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Berry Global Group, Inc.
August 4, 2017	By:	/s/ Mark W. Miles
		Mark W. Miles
		Chief Financial Officer

30

EX-31.1

EXHIBIT 31.1

CHIEF EXECUTIVE OFFICER CERTIFICATION

I, Thomas E. Salmon, Chief Executive Officer of Berry Global Group, Inc., certify that:

1.  I have reviewed this quarterly report on Form 10-Q of Berry Global Group, Inc. (the "Registrant");

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.  The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)  Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5.  The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

	By:	/s/ Thomas E. Salmon
Date: August 4, 2017		Thomas E. Salmon
		Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CHIEF FINANCIAL OFFICER CERTIFICATION

I, Mark W. Miles, Chief Financial Officer of Berry Global Group, Inc., certify that:

1.  I have reviewed this quarterly report on Form 10-Q of Berry Global Group, Inc. (the "Registrant");

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.  The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)  Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5.  The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

	By:	/s/ Mark W. Miles
Date: August 4, 2017		Mark W. Miles
		Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Berry Global Group, Inc. (the "Registrant") on Form 10-Q for the quarter ended July 1, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Thomas E. Salmon, Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

/s/ Thomas E. Salmon

Thomas E. Salmon

Chief Executive Officer

Date:  August 4, 2017

EX-32.2

EXHIBIT 32.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Berry Global Group, Inc. (the "Registrant") on Form 10-Q for the quarter ended July 1, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mark W. Miles, the Chief Financial Officer and Treasurer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

/s/ Mark W. Miles

Mark W. Miles

Chief Financial Officer

Date: August 4, 2017 

XML

Document and Entity Information - shares shares in Millions	9 Months Ended
	Jul. 01, 2017	Aug. 04, 2017
Document And Entity Information [Abstract]
Entity Registrant Name	BERRY GLOBAL GROUP INC
Entity Central Index Key	0001378992
Current Fiscal Year End Date	--09-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		130.4
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jul. 01, 2017

XML

Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Consolidated Statements of Income (Unaudited) [Abstract]
Net sales	$ 1,906	$ 1,645	$ 5,214	$ 4,871
Costs and expenses:
Cost of goods sold	1,518	1,296	4,177	3,885
Selling, general and administrative	128	129	373	421
Amortization of intangibles	40	35	113	106
Restructuring and impairment charges	8	6	18	29
Operating income	212	179	533	430
Other (income) expense, net	(1)	(14)	18	(17)
Interest expense, net	68	73	203	222
Income before income taxes	145	120	312	225
Income tax expense	38	24	82	66
Net income	$ 107	$ 96	$ 230	$ 159
Net income per share:
Basic (in dollars per share)	$ 0.82	$ 0.79	$ 1.82	$ 1.32
Diluted (in dollars per share)	$ 0.79	$ 0.76	$ 1.75	$ 1.28
Outstanding weighted-average shares:
Basic (in shares)	129.9	121.1	126.6	120.5
Diluted (in shares)	135.2	125.9	131.4	123.9

XML

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Consolidated Statements of Comprehensive Income (Unaudited) [Abstract]
Net income	$ 107	$ 96	$ 230	$ 159
Currency translation	24	(16)	4	39
Defined benefit pension and retiree health benefit plans	0	0	13	0
Interest rate hedges	(1)	(4)	23	(20)
Provision for income taxes related to other comprehensive income items	0	1	(8)	8
Other comprehensive income, net of tax	23	(19)	32	27
Comprehensive income	$ 130	$ 77	$ 262	$ 186

XML

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Jul. 01, 2017	Oct. 01, 2016
Current assets:
Cash and cash equivalents	$ 275	$ 323
Accounts receivable (less allowance of $13 and $8, respectively)	844	704
Inventories:
Finished goods	473	397
Raw materials and supplies	338	263
Inventory, total	811	660
Prepaid expenses and other current assets	92	105
Total current assets	2,022	1,792
Property, plant, and equipment, net	2,375	2,224
Goodwill and intangible assets, net	4,096	3,606
Other assets	52	31
Total assets	8,545	7,653
Current liabilities:
Accounts payable	581	539
Accrued expenses and other current liabilities	498	449
Current portion of long-term debt	34	43
Total current liabilities	1,113	1,031
Long-term debt, less current portion	5,857	5,712
Deferred income taxes	416	272
Other long-term liabilities	311	417
Total liabilities	7,697	7,432
Stockholders' equity
Common stock (130.4 and 122.0 million shares issued, respectively)	1	1
Additional paid-in capital	814	449
Non-controlling interest	3	3
Accumulated equity (deficit)	146	(84)
Accumulated other comprehensive loss	(116)	(148)
Total stockholders' equity	848	221
Total liabilities and stockholders' equity	$ 8,545	$ 7,653

XML

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) shares in Millions, $ in Millions	Jul. 01, 2017	Oct. 01, 2016
Current assets:
Accounts receivable, allowance	$ 13	$ 8
Stockholders' equity
Common stock, shares issued (in shares)	130.4	122.0

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016
Cash Flows from Operating Activities:
Net income	$ 230	$ 159
Adjustments to reconcile net cash provided by operating activities:
Depreciation	270	284
Amortization of intangibles	113	106
Non-cash interest expense	6	8
Deferred income tax	39	23
Stock compensation expense	16	17
Other non-cash operating activities, net	26	(8)
Changes in working capital	(113)	(26)
Changes in other assets and liabilities	(7)	4
Net cash from operating activities	580	567
Cash Flows from Investing Activities:
Additions to property, plant and equipment	(201)	(228)
Proceeds from sale of assets	4	4
Acquisition of business, net of cash acquired	(515)	(2,283)
Other investing activities, net	(1)	(11)
Net cash from investing activities	(713)	(2,518)
Cash Flows from Financing Activities:
Proceeds from long-term borrowings	545	2,490
Repayments on long-term borrowings	(427)	(390)
Proceeds from issuance of common stock	26	20
Payment of tax receivable agreement	(60)	(57)
Debt financing costs	(4)	(38)
Purchase of non-controlling interest	0	(66)
Net cash from financing activities	80	1,959
Effect of exchange rate changes on cash	5	0
Net change in cash	(48)	8
Cash and cash equivalents at beginning of period	323	228
Cash and cash equivalents at end of period	$ 275	$ 236

XML

Basis of Presentation

9 Months Ended

Jul. 01, 2017

Basis of Presentation [Abstract]

Basis of Presentation

1.  Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.  In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures at the date of the financial statements and during the reporting period.  Actual results could differ from those estimates.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated.  For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's most recent Form 10-K filed with the Securities and Exchange Commission.

Effective April, 2017, the Company changed its name from Berry Plastics Group, Inc. to Berry Global Group, Inc.  The new name is reflected throughout this Form 10-Q.  Common Shares of the Company stock continue to be traded on the New York Stock Exchange under the symbol BERY.  In addition Berry Plastics Corporation, a wholly owned subsidiary, changed its name to Berry Global, Inc.

XML

Recently Issued Accounting Pronouncements

9 Months Ended

Jul. 01, 2017

Recently Issued Accounting Pronouncements [Abstract]

Recently Issued Accounting Pronouncements

2. Recently Issued Accounting Pronouncements

Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates to the FASB's Accounting Standards Codification.  During fiscal 2017, with the exception of the below, there have been no developments to the recently adopted accounting pronouncements from those disclosed in the Company's 2016 Annual Report on Form 10-K that are considered to have a material impact on our unaudited consolidated financial statements.

Goodwill

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment.  To simplify the subsequent measurement of goodwill, Step 2, which was previously used to compute the implied fair value of goodwill, was eliminated.  This update requires an entity to perform its annual goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount.  An impairment will be recognized in the amount by which a reporting unit's carrying amount exceeds its fair value.  The loss recognized will not exceed the total amount of goodwill allocated to that reporting unit.  The new guidance is effective for interim and annual periods beginning after December 15, 2019 and should be applied on a prospective basis.  Early adoption is permitted.  We will adopt this guidance for our fiscal 2017 goodwill testing.

Retirement Benefits

In March 2017, the FASB issued ASU 2017-07, Compensation – Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which requires employers to report the service cost component in the same line item as other compensation costs arising from services rendered by the pertinent employees during the period.  The other components of net benefit cost are required to be presented in the income statement separately from the service cost component and outside a subtotal of income from operations. If a separate line item is used to present the other components of net benefit cost, then the line item used in the income statement to present the other components of net benefit cost must be disclosed.  The new guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied on a retrospective basis.  Early adoption is permitted.  We will adopt this guidance for our fiscal 2017 goodwill testing.

XML

Acquisitions

9 Months Ended

Jul. 01, 2017

Acquisitions [Abstract]

Acquisitions

3. Acquisitions

AEP Industries Inc.

In January 2017, the Company acquired AEP Industries Inc. (“AEP”) for a purchase price of $791 million, net of cash acquired.  A portion of the purchase price consisted of issuing 6.4 million of Berry common shares which were valued at $324 million at the time of closing.  AEP manufactures and markets an extensive and diverse line of polyethylene and polyvinyl chloride flexible plastic packaging products for consumer, industrial, and agricultural applications.  The acquired business is operated in our Engineered Materials segment.  To finance the purchase, the Company entered into an incremental assumption agreement to increase the commitments under the Company's existing term loan credit agreement by $500 million due 2024.

The acquisition has been accounted for under the purchase method of accounting, and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary fair values at the acquisition date.  The results of AEP have been included in the consolidated results of the Company since the date of the acquisition.  The Company has not finalized the allocation of the purchase price to the fair value of the assets acquired and liabilities assumed.  The Company has recognized Goodwill on this transaction primarily as a result of expected cost synergies, and does not expect Goodwill to be deductible for tax purposes.  The following table summarizes the preliminary allocation of purchase price and the estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	133
Property and equipment		222
Intangible assets		214
Goodwill		350
Historical AEP debt assumed		(7	)
Other assets and long-term liabilities		(121	)
(a) Includes a $5 million step up of inventory to fair value

Unaudited pro forma net sales were $1.9 billion for the quarterly period ended July 2, 2016.  Unaudited pro forma net sales were $5.5 billion and $5.7 billion for the three quarterly periods ended July 1, 2017 and July 2, 2016, respectively.  Unaudited pro forma net income was $102 million for the quarterly period ended July 2, 2016.  Unaudited pro forma net income was $232 million and $175 million for the three quarterly periods ended July 1, 2017 and July 2, 2016, respectively.  The unaudited pro forma net sales and net income assume that the AEP acquisition had occurred as of the beginning of the period.

Adchem Corp.

In June 2017, the Company acquired Adchem Corp.'s (“Adchem”) tapes business for a purchase price of $49 million.  Adchem is a leader in the development of high performance adhesive tape systems for the automotive, construction, electronics, graphic arts, medical and general tape markets.  The acquired business will be operated within the Engineered Materials segment.  To finance the purchase, the Company used existing liquidity.  The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary values at the acquisition date.  The Company expects Goodwill to be deductible for tax purposes.

AVINTIV Inc.

In October 2015, the Company acquired 100% of the capital stock of AVINTIV Inc. (“Avintiv”) for a purchase price of $2.26 billion, net of cash acquired.  Avintiv is one of the world’s leading developers, producers, and marketers of nonwoven specialty materials used in hygiene, infection prevention, personal care, industrial, construction, and filtration applications.  To finance the purchase, the Company issued $400 million aggregate principal amount of 6.0% second priority senior secured notes due 2022 and entered into an incremental assumption agreement to increase the commitments under the Company’s existing term loan credit agreement by $2.1 billion due 2022.  The results of Avintiv have been included in the consolidated results of the Company since the date of acquisition.

XML

Restructuring and Impairment Charges

9 Months Ended

Jul. 01, 2017

Restructuring and Impairment Charges [Abstract]

Restructuring and Impairment Charges

4.  Restructuring and Impairment Charges

The Company incurred restructuring costs related to severance, asset impairment, and facility exit costs.  The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended				Three Quarterly Periods Ended
	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Consumer Packaging	$	2	$	2	$	6	$	7
Health, Hygiene & Specialties		4		4		8		20
Engineered Materials		2		—		4		2
Consolidated	$	8	$	6	$	18	$	29

The table below sets forth the activity with respect to the restructuring accrual at July 1, 2017:

	Severance and termination benefits			Facilities exit costs and other			Total
Balance at October 1, 2016	$	7		$	6		$	13
Charges		14			4			18
Cash payments		(15	)		(6	)		(21	)
Balance at July 1, 2017	$	6		$	4		$	10

XML

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

9 Months Ended

Jul. 01, 2017

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

5. Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	July 1, 2017		October 1, 2016
Employee compensation, payroll and other	$	128	$	152
Interest		33		53
Rebates		54		54
Restructuring		10		13
Accrued taxes		77		40
Tax receivable agreement obligation		101		60
Accrued operating expenses		95		77
	$	498	$	449

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	July 1, 2017		October 1, 2016
Lease retirement obligation	$	36	$	34
Sale-lease back deferred gain		24		26
Pension liability		82		88
Deferred purchase price		43		41
Tax receivable agreement obligation		22		114
Interest rate swaps		35		45
Other		69		69
	$	311	$	417

The Company made $60 million of payments related to the income tax receivable agreement ("TRA") in the December 31, 2016 quarter, of which Apollo Global Management, LLC received $48 million. The TRA provides for an annual payment to TRA holders equal to 85% of the amount of cash savings, if any, in U.S. federal, foreign, state and local income tax that are actually realized as a result of the utilization of our net operating losses attributable to periods prior to the initial public offering.

XML

Long-Term Debt

9 Months Ended

Jul. 01, 2017

Long-Term Debt [Abstract]

Long-Term Debt

6. Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	July 1, 2017			October 1, 2016
Term loan	February 2020	$	1,148		$	1,351
Term loan	January 2021		814			814
Term loan	October 2022		1,695			1,895
Term loan	January 2024		499			—
Revolving line of credit	May 2020		50			—
5 1/8% Second Priority Senior Secured Notes	July 2023		700			700
5 1/2% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
Debt discounts and deferred fees			(52	)		(58	)
Capital leases and other	Various		137			153
Total long-term debt			5,891			5,755
Current portion of long-term debt			(34	)		(43	)
Long-term debt, less current portion		$	5,857		$	5,712

The Company was in compliance with all covenants for all periods presented.

Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense through maturity.

Term Loans

In January 2017, the Company entered into an incremental assumption agreement to increase the commitments under the existing term loan credit agreement by $500 million in order to finance the AEP acquisition.  The incremental assumption agreement provided for the $500 million incremental term loan to bear interest at LIBOR plus 2.50% per annum with no LIBOR floor, to mature in January 2024 and to be subject to customary amortization.  During the March ending quarter the Company executed an amendment to lower the interest rates under certain of the term loans.  The term loans maturing in October 2022 bear interest at LIBOR plus 2.50% with no LIBOR floor.  The term loans maturing in February 2020 and January 2021 bear interest at LIBOR plus 2.25% with no LIBOR floor.

During fiscal 2017, the Company has made $427 million of repayments on long-term borrowings using existing liquidity.  As a result of the current year prepayments and modifications, the Company recorded a $3 million loss on debt extinguishment in Other (income) expense, net, reflecting the write-off of deferred financing fees and debt discounts, net of amortization associated with the portion of the debt that was considered extinguished.  Additionally, the Company recognized $9 million of debt discounts and deferred financing fees related to the incremental assumption agreements and amendments.

XML

Financial Instruments and Fair Value Measurements

9 Months Ended

Jul. 01, 2017

Financial Instruments and Fair Value Measurements [Abstract]

Financial Instruments and Fair Value Measurements

7. Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors.  The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies.  These financial instruments are not used for trading or other speculative purposes. 

The Company designates derivative instruments that qualify as hedging instruments, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.  To the extent hedging relationships are found to be effective, which is evaluated quarterly, changes in the fair value of the derivatives are offset by changes in the fair value of the related hedged item and recorded to Accumulated other comprehensive loss. 

The Company records the changes in the fair value of derivatives that are not designated as hedging instruments to the Consolidated Statements of Income.

Foreign Currency Forward Contracts

The primary purpose of the Company's foreign currency hedging activities is to manage the potential changes in value associated with the changes in foreign currencies on future foreign cash movements for certain jurisdictions.  The changes in fair value of these derivative contracts are recognized in Other (income) expense, net on the Consolidated Statements of Income and are largely offset by the remeasurement of the underlying intercompany loan.  When valuing foreign currency forward contracts the Company utilizes Level 2 (significant observable inputs) fair value measurements.  These contracts are typically entered into and settled within the given quarterly reporting period.

Interest Rate Swaps - Cash Flow Hedges

The primary purpose of our interest rate swaps is to manage cash flow variability associated with our outstanding variable rate term loan debt.  At inception these contracts are designed as effective cash flow hedges.  When valuing interest rate swaps we utilize derivative Level 2 (significant observable inputs) fair value measurements.  For interest rate swaps that are designated and qualify as cash flow hedges, the effective portion of the gain or loss is reported as a component of Accumulated other comprehensive loss.

Cash flow hedge accounting is discontinued when it is determined that an interest rate swap no longer qualifies as an effective hedge.  When cash flow hedge accounting is de-designated, the swap is subject to the mark-to-market method of accounting prospectively.  Changes in the mark-to-market fair value of the de-designated instrument are recorded to the Consolidated Statements of Income. Unrealized gains and losses that were previously deferred in Accumulated other comprehensive loss are amortized to Interest expense over the remaining term of the swap.

Interest Rate Swap Arrangements

In February 2013, the Company entered into a $1 billion interest rate swap transaction with an effective date of May 2016 and expiration in May 2019.  In June 2013, the Company elected to settle this derivative instrument and received $16 million as a result of this settlement.  The offset is included in Accumulated other comprehensive loss and is being amortized to Interest expense from May 2016 through May 2019, the original term of the swap agreement.

In March 2014, the Company entered into a $1 billion interest rate swap transaction with an effective date of February 2016 and expiration in February 2019.  In February 2017, in conjunction with the term loan modifications, the Company discontinued hedge accounting.  Previously unrealized losses in Accumulated other comprehensive loss were being amortized to Interest expense through February 2019, the original term of the swap.  In order to offset the impact of future fair value changes of the March 2014 de-designated swap, the Company entered into a mirrored offsetting swap in February 2017 and has not designated it as a hedge.

In September 2015, the Company entered into a $1 billion interest rate swap transaction with an effective date of December 2015 and expiration in June 2019.  In February 2017, in conjunction with the term loan modifications, the Company entered into an agreement to modify the terms of the original swap on a prospective basis.  At that time, the Company de-designated the hedge and has re-designated the modified swap as an effective cash flow hedge.  The amount included in Accumulated other comprehensive loss at the date of de-designation is being amortized to Interest expense through June 2019, the original term of the swap.  The modified agreement swaps a one-month variable LIBOR contract for a fixed annual rate of 1.5190% with an effective date in March 2017 and expiration in June 2019.

In January 2017, the Company entered into a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.00%, with an effective date in May 2017 and expiration in May 2022.  

In February 2017, the Company entered into a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.3785% with an effective date in February 2017 and expiration in February 2019.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances as of the current period are as follows;

Derivatives Instruments	Hedge Designation	Balance Sheet Location	July 1, 2017		October 1, 2016
Foreign currency forward contracts	Not designated	Other assets	$	3	$	3
Interest rate swaps	Not designated	Other assets		17		—
Interest rate swaps	Designated	Other long-term liabilities		18		35
Interest rate swaps	Not designated	Other long-term liabilities		17		—

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended				Three Quarterly Periods Ended
Derivatives instruments	Statements of Income Location	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Interest rate swaps	Interest expense, net	$	5	$	6	$	15	$	10
Foreign currency forward contracts	Other (income) expense, net	$	1	$	3	$	—	$	9

The amortization related to unrealized losses in Accumulated other comprehensive loss is expected to be $2 million in the next 12 months.

Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present.  The assets are adjusted to fair value only when the carrying values exceed the fair values.  The categorization of the framework used to price the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value.  These assets include primarily our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant, and equipment.  The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year, and more frequently if impairment indicators exist.  The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2016 assessment.  No impairment indicators were identified in the current quarter.

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of July 1, 2017 and October 1, 2016, along with the impairment loss recognized on the fair value measurement during the period:

	As of July 1, 2017
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,782		2,782		—
Definite lived intangible assets		—		—		1,066		1,066		—
Property, plant, and equipment		—		—		2,375		2,375		—
Total	$	—	$	—	$	6,471	$	6,471	$	—

	As of October 1, 2016
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,406		2,406		—
Definite lived intangible assets		—		—		952		952		—
Property, plant, and equipment		—		—		2,224		2,224		3
Total	$	—	$	—	$	5,830	$	5,830	$	3

The Company's financial instruments consist primarily of cash and cash equivalents and long-term debt.  The fair value of our marketable long-term indebtedness exceeded book value by $76 million as of July 1, 2017.  The Company's long-term debt fair values were determined using Level 2 inputs as other significant observable inputs were not available.

XML

Income Taxes

9 Months Ended

Jul. 01, 2017

Income Taxes [Abstract]

Income Taxes

8.  Income Taxes

The Company's effective tax rate was 26% for the quarterly period and three quarterly periods ended July 1, 2017.  Within the quarter, the effective tax rate was favorably impacted by 9% from the discrete item related to share based compensation excess tax benefit.  Our year-to-date effective tax rate of 26% was favorably impacted by 9% from the discrete item related to share based compensation excess tax benefit and a 3% state valuation allowance release, partially offset by a negative impact of 2% due to state taxes and a 2% foreign valuation allowance.

XML

Operating Segments

9 Months Ended

Jul. 01, 2017

Operating Segments [Abstract]

Operating Segments

9.  Operating Segments

The Company's operations are organized into three operating segments: Consumer Packaging, Health, Hygiene & Specialties, and Engineered Materials.  The structure is designed to align us with our customers, provide improved service, and drive future growth in a cost efficient manner.  In October 2016, the Company realigned portions of our operating segments in order to leverage geographic management teams and commercial activities.  The international portion of our Retail & Industrial product line was moved from Engineered Materials to the Specialties product line within Health, Hygiene & Specialties, resulting in a $39 million and $108 million movement in Net sales in the quarterly and three quarterly periods ended July 2, 2016, respectively.  Additionally, to align the newly acquired AEP business with our existing Core Films business, $73 million and $230 million of Net sales were moved from Consumer Packaging to Engineered Materials in the quarterly and three quarterly periods ended July 2, 2016, respectively.  As result of these organizational realignments, we have recast prior period segment amounts.  Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended				Three Quarterly Periods Ended
	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Net sales:
Consumer Packaging	$	614	$	631	$	1,752	$	1,845
Health, Hygiene & Specialties		606		606		1,773		1,807
Engineered Materials		686		408		1,689		1,219
Total net sales	$	1,906	$	1,645	$	5,214	$	4,871
Operating income:
Consumer Packaging	$	60	$	58	$	150	$	156
Health, Hygiene & Specialties		53		69		164		140
Engineered Materials		99		52		219		134
Total operating income	$	212	$	179	$	533	$	430
Depreciation and amortization:
Consumer Packaging	$	56	$	61	$	174	$	183
Health, Hygiene & Specialties		46		38		136		143
Engineered Materials		30		21		73		64
Total depreciation and amortization	$	132	$	120	$	383	$	390

	July 1, 2017		October 1, 2016
Total assets:
Consumer Packaging	$	3,268	$	3,315
Health, Hygiene & Specialties		3,441		3,504
Engineered Materials		1,836		834
Total assets	$	8,545	$	7,653

Selected information by geography is presented in the following tables:

	Quarterly Period Ended				Three Quarterly Periods Ended
	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Net sales:
North America	$	1,591	$	1,329	$	4,289	$	3,939
South America		85		88		246		247
Europe		165		166		482		505
Asia		65		62		197		180
Total net sales	$	1,906	$	1,645	$	5,214	$	4,871

	July 1, 2017		October 1, 2016
Long-lived assets:
North America	$	5,420	$	4,724
South America		360		386
Europe		459		462
Asia		284		289
Total Long-lived assets	$	6,523	$	5,861

Selected information by product line is presented in the following tables:

	Quarterly Period Ended						Three Quarterly Periods Ended
(in percentages)	July 1, 2017			July 2, 2016			July 1, 2017			July 2, 2016
Net sales:
Rigid Open Top		44	%		43	%		42	%		42	%
Rigid Closed Top		56			57			58			58
Consumer Packaging		100	%		100	%		100	%		100	%
Health		22	%		21	%		22	%		20	%
Hygiene		44			45			44			45
Specialties		34			34			34			35
Health, Hygiene & Specialties		100	%		100	%		100	%		100	%
Core Films		43	%		72	%		51	%		71	%
Retail & Industrial		57			28			49			29
Engineered Materials		100	%		100	%		100	%		100	%

Goodwill  

In connection with the change in reporting segments, the Company reallocated goodwill to the segments under the provisions of ASC 350.  The changes in the carrying amount of goodwill by reportable segment are as follows:  

	Consumer Packaging			Health, Hygiene & Specialties		Engineered Materials		Total
Balance as of October 1, 2016	$	1,520		$	801	$	85	$	2,406
Segment reorganization		(110	)		7		103		—
Acquisition, net		—			—		376		376
Foreign currency translation adjustment		—			—		—		—
Balance as of July 1, 2017	$	1,410		$	808	$	564	$	2,782

XML

Contingencies and Commitments

9 Months Ended

Jul. 01, 2017

Contingencies and Commitments [Abstract]

Contingencies and Commitments

10.  Contingencies and Commitments

The Company is party to various legal proceedings involving routine claims which are incidental to its business.  Although the Company's legal and financial liability with respect to such proceedings cannot be estimated with certainty, management believes that any ultimate liability would not be material to its financial statements.

The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

XML

Basic and Diluted Net Income per Share

9 Months Ended

Jul. 01, 2017

Basic and Diluted Net Income per Share [Abstract]

Basic and Diluted Net Income per Share

11.  Basic and Diluted Net Income per Share

Basic net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents.  Diluted net income per share is computed by dividing the net income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method and the if-converted method.  For purposes of this calculation, stock options are considered to be common stock equivalents and are only included in the calculation of diluted net income per share when their effect is dilutive. There were no shares excluded from the calculations as the effect of their conversion into shares of our common stock would be antidilutive.

The following tables and discussion provide a reconciliation of the numerator and denominator of the basic and diluted net income per share computations.

	Quarterly Period Ended				Three Quarterly Periods Ended
(in millions, except per share amounts)	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Numerator
Net income	$	107	$	96	$	230	$	159
Denominator
Weighted average common shares outstanding - basic		129.9		121.1		126.6		120.5
Dilutive shares		5.3		4.8		4.8		3.4
Weighted average common and common equivalent shares outstanding - diluted		135.2		125.9		131.4		123.9
Per common share income
Basic	$	0.82	$	0.79	$	1.82	$	1.32
Diluted	$	0.79	$	0.76	$	1.75	$	1.28

XML

Accumulated Other Comprehensive Income (Loss)

9 Months Ended

Jul. 01, 2017

Accumulated Other Comprehensive Income (Loss) [Abstract]

Accumulated Other Comprehensive Income (Loss)

12.  Accumulated Other Comprehensive Income (Loss)

The components and activity of Accumulated other comprehensive income (loss) are as follows: 

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps Designated as Hedges			Interest Rate Swaps Not Designated as Hedges			Accumulated Other Comprehensive Income (Loss)
Balance at October 1, 2016	$	(82	)	$	(44	)	$	(31	)	$	9		$	(148	)
De-designated hedges		—			—			17			(17	)		—
Other comprehensive income (loss) before reclassifications		4			13			5			—			22
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			17			1			18
Provision for income taxes related to other comprehensive income items		—			—			(8	)		—			(8	)
Balance at July 1, 2017	$	(78	)	$	(31	)	$	—		$	(7	)	$	(116	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps Designated as Hedges			Interest Rate Swaps Not Designated as Hedges		Accumulated Other Comprehensive Income (Loss)
Balance at September 26, 2015	$	(81	)	$	(25	)	$	(23	)	$	10	$	(119	)
Other comprehensive income (loss) before reclassifications		39			—			(30	)		—		9
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			10			—		10
Provision for income taxes related to other comprehensive income items		—			—			8			—		8
Balance at July 2, 2016	$	(42	)	$	(25	)	$	(35	)	$	10	$	(92	)

XML

Guarantor and Non-Guarantor Financial Information

9 Months Ended

Jul. 01, 2017

Guarantor and Non-Guarantor Financial Information [Abstract]

Guarantor and Non-Guarantor Financial Information

13.  Guarantor and Non-Guarantor Financial Information

Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this Note, “Parent”) and substantially all of Issuer’s domestic subsidiaries.  Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis.  A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances:  the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture, as a result of the holders of certain other indebtedness foreclosing on a pledge of the shares of a guarantor subsidiary or if such guarantor no longer guarantees certain other indebtedness of the issuer.  The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company’s debts.  Parent also guarantees the Issuer’s term loans and revolving credit facilities.  The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility.  Presented below is condensed consolidating financial information for the Parent, Issuer, guarantor subsidiaries and non-guarantor subsidiaries.  The Issuer and guarantor financial information includes all of our domestic operating subsidiaries; our non-guarantor subsidiaries include our foreign subsidiaries, certain immaterial domestic subsidiaries and the unrestricted subsidiaries under the Issuer’s indentures.  The Parent uses the equity method to account for its ownership in the Issuer in the Condensed Consolidating Supplemental Financial Statements.  The Issuer uses the equity method to account for its ownership in the guarantor and non-guarantor subsidiaries.  All consolidating entries are included in the eliminations column along with the elimination of intercompany balances.

Condensed Supplemental Consolidated Balance Sheet

	July 1, 2017
	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	80	$	1,188	$	754	$	—		$	2,022
Intercompany receivable		518		2,512		—		—		(3,030	)		—
Property, plant, and equipment, net		—		74		1,591		710		—			2,375
Other assets		868		5,217		4,578		523		(7,038	)		4,148
Total assets	$	1,386	$	7,883	$	7,357	$	1,987	$	(10,068	)	$	8,545
Current liabilities	$	101	$	167	$	563	$	282	$	—		$	1,113
Intercompany payable		—		66		2,819		145		(3,030	)		—
Other long-term liabilities		437		5,976		105		66		—			6,584
Stockholders' equity (deficit)		848		1,674		3,870		1,494		(7,038	)		848
Total liabilities and stockholders' equity	$	1,386	$	7,883	$	7,357	$	1,987	$	(10,068	)	$	8,545

	October 1, 2016
	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	161	$	945	$	686	$	—		$	1,792
Intercompany receivable		364		2,797		—		—		(3,161	)		—
Property, plant and equipment, net		—		76		1,434		714		—			2,224
Other assets		302		4,101		4,094		557		(5,417	)		3,637
Total assets	$	666	$	7,135	$	6,473	$	1,957	$	(8,578	)	$	7,653
Current liabilities	$	60	$	207	$	480	$	284	$	—		$	1,031
Intercompany payable		—		—		2,992		169		(3,161	)		—
Other long-term liabilities		385		5,822		126		68		—			6,401
Stockholders' equity (deficit)		221		1,106		2,875		1,436		(5,417	)		221
Total liabilities and stockholders' equity	$	666	$	7,135	$	6,473	$	1,957	$	(8,578	)	$	7,653

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended July 1, 2017
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	152		$	1,325		$	429		$	—		$	1,906
Cost of goods sold		—			100			1,059			359			—			1,518
Selling, general and administrative		—			14			89			25			—			128
Amortization of intangibles		—			2			31			7			—			40
Restructuring and impairment charges		—			—			—			8			—			8
Operating income		—			36			146			30			—			212
Other expense (income), net		—			1			(1	)		(1	)		—			(1	)
Interest expense, net		—			5			47			16			—			68
Equity in net income of subsidiaries		(145	)		(109	)		—			—			254			—
Income before income taxes		145			139			100			15			(254	)		145
Income tax expense		38			32			—			6			(38	)		38
Net income	$	107		$	107		$	100		$	9		$	(216	)	$	107
Comprehensive net income	$	107		$	102		$	100		$	37		$	(216	)	$	130

	Quarterly Period Ended July 2, 2016
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	150		$	1,081		$	414		$	—		$	1,645
Cost of goods sold		—			140			834			322			—			1,296
Selling, general and administrative		—			6			93			30			—			129
Amortization of intangibles		—			2			27			6			—			35
Restructuring and impairment charges		—			—			1			5			—			6
Operating income		—			2			126			51			—			179
Other expense (income), net		—			8			(4	)		(18	)		—			(14	)
Interest expense, net		—			9			63			1			—			73
Equity in net income of subsidiaries		(120	)		(119	)		—			—			239			—
Income before income taxes		120			104			67			68			(239	)		120
Income tax expense		24			4			1			14			(19	)		24
Net income	$	96		$	100		$	66		$	54		$	(220	)	$	96
Comprehensive net income	$	96		$	98		$	65		$	38		$	(220	)	$	77

	Three Quarterly Periods Ended July 1, 2017
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	441		$	3,556		$	1,217		$	—		$	5,214
Cost of goods sold		—			333			2,860			984			—			4,177
Selling, general and administrative		—			45			251			77			—			373
Amortization of intangibles		—			5			87			21			—			113
Restructuring and impairment charges		—			—			10			8			—			18
Operating income		—			58			348			127			—			533
Other expense (income), net		—			15			1			2			—			18
Interest expense, net		—			17			138			48			—			203
Equity in net income of subsidiaries		(312	)		(252	)		—			—			564			—
Income before income taxes		312			278			209			77			(564	)		312
Income tax expense		82			48			—			34			(82	)		82
Net income	$	230		$	230		$	209		$	43		$	(482	)	$	230
Comprehensive net income	$	230		$	245		$	209		$	60		$	(482	)	$	262
Consolidating Statement of Cash Flows
Cash Flow from Operating Activities	$	—		$	31		$	420		$	129		$	—		$	580
Cash Flow from Investing Activities
Additions to  property, plant, and equipment		—			(11	)		(160	)		(30	)		—			(201	)
Proceeds from sale of assets		—			1			3			—			—			4
Contributions (to)/from subsidiaries		(26	)		(489	)		—			—			515			—
Intercompany		—			280			—			—			(280	)		—
Acquisition of business, net of cash acquired		—			—			(515	)		—			—			(515	)
Other investing activities, net		—			(1	)		—			—			—			(1	)
Net cash from investing activities		(26	)		(220	)		(672	)		(30	)		235			(713	)
Cash Flow from Financing Activities
Proceeds from long-term debt		—			545			—			—			—			545
Proceeds from issuance of common stock		26			—			—			—			—			26
Payment of tax receivable agreement		(60	)		—			—			—			—			(60	)
Repayments on long-term borrowings		—			(423	)		(3	)		(1	)		—			(427	)
Contribution from Parent		—			—			515			—			(515	)		—
Debt financing costs		—			(4	)		—			—			—			(4	)
Changes in intercompany balances		60			—			(255	)		(85	)		280			—
Net cash from financing activities		26			118			257			(86	)		(235	)		80
Effect of exchange rate changes on cash		—			—			—			5			—			5
Net change in cash		—			(71	)		5			18			—			(48	)
Cash and cash equivalents at beginning of period		—			102			5			216			—			323
Cash and cash equivalents at end of period	$	—		$	31		$	10		$	234		$	—		$	275

	Three Quarterly Periods Ended July 2, 2016
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	442		$	3,143		$	1,286		$	—		$	4,871
Cost of goods sold		—			373			2,490			1,022			—			3,885
Selling, general and administrative		—			89			251			81			—			421
Amortization of intangibles		—			6			77			23			—			106
Restructuring and impairment charges		—			—			23			6			—			29
Operating income		—			(26	)		302			154			—			430
Other expense (income), net		—			19			(11	)		(25	)		—			(17	)
Interest expense, net		—			27			158			37			—			222
Equity in net income of subsidiaries		(225	)		(258	)		—			—			483			—
Income before income taxes		225			186			155			142			(483	)		225
Income tax expense		66			23			2			36			(61	)		66
Net income	$	159		$	163		$	153		$	106		$	(422	)	$	159
Comprehensive net income	$	159		$	152		$	152		$	145		$	(422	)	$	186
Consolidating Statement of Cash Flows
Cash Flow from Operating Activities	$	—		$	23		$	382		$	162		$	—		$	567
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(13	)		(181	)		(34	)		—			(228	)
Proceeds from sale of assets		—			—			4			—			—			4
Contributions (to)/from subsidiaries		(20	)		(2,240	)		—			—			2,260			—
Intercompany		—			11			—			—			(11	)		—
Acquisition of business, net of cash acquired		—			—			(291	)		(1,992	)		—			(2,283	)
Other investing activities, net		—			(11	)		—			—			—			(11	)
Net cash from investing activities		(20	)		(2,253	)		(468	)		(2,026	)		2,249			(2,518	)
Cash Flow from Financing Activities
Proceeds from long-term debt		—			2,490			—			—			—			2,490
Repayments on long-term borrowings		—			(356	)		—			(34	)		—			(390	)
Proceeds from issuance of common stock		20			—			—			—			—			20
Payment of tax receivable agreement		(57	)		—			—			—			—			(57	)
Contribution from parent		—			—			291			1,969			(2,260	)		—
Debt financing costs		—			(38	)		—			—			—			(38	)
Purchase of non-controlling interest		—			—			(66	)		—			—			(66	)
Changes in intercompany balances		57			—			(110	)		42			11			—
Net cash from financing activities		20			2,096			115			1,977			(2,249	)		1,959
Effect of exchange rate changes on cash		—			—			—			—			—			—
Net change in cash		—			(134	)		29			113			—			8
Cash and cash equivalents at beginning of period		—			163			—			65			—			228
Cash and cash equivalents at end of period	$	—		$	29		$	29		$	178		$	—		$	236

XML

Recently Issued Accounting Pronouncements (Policies)

9 Months Ended

Jul. 01, 2017

Recently Issued Accounting Pronouncements [Abstract]

Goodwill

Goodwill

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment.  To simplify the subsequent measurement of goodwill, Step 2, which was previously used to compute the implied fair value of goodwill, was eliminated.  This update requires an entity to perform its annual goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount.  An impairment will be recognized in the amount by which a reporting unit's carrying amount exceeds its fair value.  The loss recognized will not exceed the total amount of goodwill allocated to that reporting unit.  The new guidance is effective for interim and annual periods beginning after December 15, 2019 and should be applied on a prospective basis.  Early adoption is permitted.  We will adopt this guidance for our fiscal 2017 goodwill testing.

Retirement Benefits

Retirement Benefits

In March 2017, the FASB issued ASU 2017-07, Compensation – Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which requires employers to report the service cost component in the same line item as other compensation costs arising from services rendered by the pertinent employees during the period.  The other components of net benefit cost are required to be presented in the income statement separately from the service cost component and outside a subtotal of income from operations. If a separate line item is used to present the other components of net benefit cost, then the line item used in the income statement to present the other components of net benefit cost must be disclosed.  The new guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied on a retrospective basis.  Early adoption is permitted.  We will adopt this guidance for our fiscal 2017 goodwill testing.

XML

Acquisitions (Tables)

9 Months Ended

Jul. 01, 2017

Acquisitions [Abstract]

Summary of Acquisition

The following table summarizes the preliminary allocation of purchase price and the estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	133
Property and equipment		222
Intangible assets		214
Goodwill		350
Historical AEP debt assumed		(7	)
Other assets and long-term liabilities		(121	)
(a) Includes a $5 million step up of inventory to fair value

XML

Restructuring and Impairment Charges (Tables)

9 Months Ended

Jul. 01, 2017

Restructuring and Impairment Charges [Abstract]

Restructuring Charges by Segment

The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended				Three Quarterly Periods Ended
	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Consumer Packaging	$	2	$	2	$	6	$	7
Health, Hygiene & Specialties		4		4		8		20
Engineered Materials		2		—		4		2
Consolidated	$	8	$	6	$	18	$	29

Restructuring Accrual Activity

The table below sets forth the activity with respect to the restructuring accrual at July 1, 2017:

	Severance and termination benefits			Facilities exit costs and other			Total
Balance at October 1, 2016	$	7		$	6		$	13
Charges		14			4			18
Cash payments		(15	)		(6	)		(21	)
Balance at July 1, 2017	$	6		$	4		$	10

XML

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities (Tables)

9 Months Ended

Jul. 01, 2017

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses and Other Current Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	July 1, 2017		October 1, 2016
Employee compensation, payroll and other	$	128	$	152
Interest		33		53
Rebates		54		54
Restructuring		10		13
Accrued taxes		77		40
Tax receivable agreement obligation		101		60
Accrued operating expenses		95		77
	$	498	$	449

Other Long-Term Liabilities

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	July 1, 2017		October 1, 2016
Lease retirement obligation	$	36	$	34
Sale-lease back deferred gain		24		26
Pension liability		82		88
Deferred purchase price		43		41
Tax receivable agreement obligation		22		114
Interest rate swaps		35		45
Other		69		69
	$	311	$	417

XML

Long-Term Debt (Tables)

9 Months Ended

Jul. 01, 2017

Long-Term Debt [Abstract]

Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	July 1, 2017			October 1, 2016
Term loan	February 2020	$	1,148		$	1,351
Term loan	January 2021		814			814
Term loan	October 2022		1,695			1,895
Term loan	January 2024		499			—
Revolving line of credit	May 2020		50			—
5 1/8% Second Priority Senior Secured Notes	July 2023		700			700
5 1/2% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
Debt discounts and deferred fees			(52	)		(58	)
Capital leases and other	Various		137			153
Total long-term debt			5,891			5,755
Current portion of long-term debt			(34	)		(43	)
Long-term debt, less current portion		$	5,857		$	5,712

XML

Financial Instruments and Fair Value Measurements (Tables)

9 Months Ended

Jul. 01, 2017

Financial Instruments and Fair Value Measurements [Abstract]

Fair Value of Derivatives and Location on Consolidated Balance Sheets

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances as of the current period are as follows;

Derivatives Instruments	Hedge Designation	Balance Sheet Location	July 1, 2017		October 1, 2016
Foreign currency forward contracts	Not designated	Other assets	$	3	$	3
Interest rate swaps	Not designated	Other assets		17		—
Interest rate swaps	Designated	Other long-term liabilities		18		35
Interest rate swaps	Not designated	Other long-term liabilities		17		—

Effect of Derivatives on Consolidated Statements of Income

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended				Three Quarterly Periods Ended
Derivatives instruments	Statements of Income Location	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Interest rate swaps	Interest expense, net	$	5	$	6	$	15	$	10
Foreign currency forward contracts	Other (income) expense, net	$	1	$	3	$	—	$	9

Assets Measured at Fair Value on Non-recurring Basis

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of July 1, 2017 and October 1, 2016, along with the impairment loss recognized on the fair value measurement during the period:

	As of July 1, 2017
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,782		2,782		—
Definite lived intangible assets		—		—		1,066		1,066		—
Property, plant, and equipment		—		—		2,375		2,375		—
Total	$	—	$	—	$	6,471	$	6,471	$	—

	As of October 1, 2016
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,406		2,406		—
Definite lived intangible assets		—		—		952		952		—
Property, plant, and equipment		—		—		2,224		2,224		3
Total	$	—	$	—	$	5,830	$	5,830	$	3

XML

Operating Segments (Tables)

9 Months Ended

Jul. 01, 2017

Operating Segments [Abstract]

Selected Information by Reportable Segment

Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended				Three Quarterly Periods Ended
	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Net sales:
Consumer Packaging	$	614	$	631	$	1,752	$	1,845
Health, Hygiene & Specialties		606		606		1,773		1,807
Engineered Materials		686		408		1,689		1,219
Total net sales	$	1,906	$	1,645	$	5,214	$	4,871
Operating income:
Consumer Packaging	$	60	$	58	$	150	$	156
Health, Hygiene & Specialties		53		69		164		140
Engineered Materials		99		52		219		134
Total operating income	$	212	$	179	$	533	$	430
Depreciation and amortization:
Consumer Packaging	$	56	$	61	$	174	$	183
Health, Hygiene & Specialties		46		38		136		143
Engineered Materials		30		21		73		64
Total depreciation and amortization	$	132	$	120	$	383	$	390

	July 1, 2017		October 1, 2016
Total assets:
Consumer Packaging	$	3,268	$	3,315
Health, Hygiene & Specialties		3,441		3,504
Engineered Materials		1,836		834
Total assets	$	8,545	$	7,653

Selected Information by Geography

Selected information by geography is presented in the following tables:

	Quarterly Period Ended				Three Quarterly Periods Ended
	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Net sales:
North America	$	1,591	$	1,329	$	4,289	$	3,939
South America		85		88		246		247
Europe		165		166		482		505
Asia		65		62		197		180
Total net sales	$	1,906	$	1,645	$	5,214	$	4,871

	July 1, 2017		October 1, 2016
Long-lived assets:
North America	$	5,420	$	4,724
South America		360		386
Europe		459		462
Asia		284		289
Total Long-lived assets	$	6,523	$	5,861

Selected Information by Product Line

Selected information by product line is presented in the following tables:

	Quarterly Period Ended						Three Quarterly Periods Ended
(in percentages)	July 1, 2017			July 2, 2016			July 1, 2017			July 2, 2016
Net sales:
Rigid Open Top		44	%		43	%		42	%		42	%
Rigid Closed Top		56			57			58			58
Consumer Packaging		100	%		100	%		100	%		100	%
Health		22	%		21	%		22	%		20	%
Hygiene		44			45			44			45
Specialties		34			34			34			35
Health, Hygiene & Specialties		100	%		100	%		100	%		100	%
Core Films		43	%		72	%		51	%		71	%
Retail & Industrial		57			28			49			29
Engineered Materials		100	%		100	%		100	%		100	%

Goodwill

The changes in the carrying amount of goodwill by reportable segment are as follows:  

	Consumer Packaging			Health, Hygiene & Specialties		Engineered Materials		Total
Balance as of October 1, 2016	$	1,520		$	801	$	85	$	2,406
Segment reorganization		(110	)		7		103		—
Acquisition, net		—			—		376		376
Foreign currency translation adjustment		—			—		—		—
Balance as of July 1, 2017	$	1,410		$	808	$	564	$	2,782

XML

Basic and Diluted Net Income per Share (Tables)

9 Months Ended

Jul. 01, 2017

Basic and Diluted Net Income per Share [Abstract]

Basic and Diluted Net Income Per Share

The following tables and discussion provide a reconciliation of the numerator and denominator of the basic and diluted net income per share computations.

	Quarterly Period Ended				Three Quarterly Periods Ended
(in millions, except per share amounts)	July 1, 2017		July 2, 2016		July 1, 2017		July 2, 2016
Numerator
Net income	$	107	$	96	$	230	$	159
Denominator
Weighted average common shares outstanding - basic		129.9		121.1		126.6		120.5
Dilutive shares		5.3		4.8		4.8		3.4
Weighted average common and common equivalent shares outstanding - diluted		135.2		125.9		131.4		123.9
Per common share income
Basic	$	0.82	$	0.79	$	1.82	$	1.32
Diluted	$	0.79	$	0.76	$	1.75	$	1.28

XML

Accumulated Other Comprehensive Income (Loss) (Tables)

9 Months Ended

Jul. 01, 2017

Accumulated Other Comprehensive Income (Loss) [Abstract]

Accumulated Other Comprehensive Income (Loss)

The components and activity of Accumulated other comprehensive income (loss) are as follows: 

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps Designated as Hedges			Interest Rate Swaps Not Designated as Hedges			Accumulated Other Comprehensive Income (Loss)
Balance at October 1, 2016	$	(82	)	$	(44	)	$	(31	)	$	9		$	(148	)
De-designated hedges		—			—			17			(17	)		—
Other comprehensive income (loss) before reclassifications		4			13			5			—			22
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			17			1			18
Provision for income taxes related to other comprehensive income items		—			—			(8	)		—			(8	)
Balance at July 1, 2017	$	(78	)	$	(31	)	$	—		$	(7	)	$	(116	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps Designated as Hedges			Interest Rate Swaps Not Designated as Hedges		Accumulated Other Comprehensive Income (Loss)
Balance at September 26, 2015	$	(81	)	$	(25	)	$	(23	)	$	10	$	(119	)
Other comprehensive income (loss) before reclassifications		39			—			(30	)		—		9
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			10			—		10
Provision for income taxes related to other comprehensive income items		—			—			8			—		8
Balance at July 2, 2016	$	(42	)	$	(25	)	$	(35	)	$	10	$	(92	)

XML

Guarantor and Non-Guarantor Financial Information (Tables)

9 Months Ended

Jul. 01, 2017

Guarantor and Non-Guarantor Financial Information [Abstract]

Condensed Supplemental Consolidated Financial Information

Condensed Supplemental Consolidated Balance Sheet

	July 1, 2017
	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	80	$	1,188	$	754	$	—		$	2,022
Intercompany receivable		518		2,512		—		—		(3,030	)		—
Property, plant, and equipment, net		—		74		1,591		710		—			2,375
Other assets		868		5,217		4,578		523		(7,038	)		4,148
Total assets	$	1,386	$	7,883	$	7,357	$	1,987	$	(10,068	)	$	8,545
Current liabilities	$	101	$	167	$	563	$	282	$	—		$	1,113
Intercompany payable		—		66		2,819		145		(3,030	)		—
Other long-term liabilities		437		5,976		105		66		—			6,584
Stockholders' equity (deficit)		848		1,674		3,870		1,494		(7,038	)		848
Total liabilities and stockholders' equity	$	1,386	$	7,883	$	7,357	$	1,987	$	(10,068	)	$	8,545

	October 1, 2016
	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	161	$	945	$	686	$	—		$	1,792
Intercompany receivable		364		2,797		—		—		(3,161	)		—
Property, plant and equipment, net		—		76		1,434		714		—			2,224
Other assets		302		4,101		4,094		557		(5,417	)		3,637
Total assets	$	666	$	7,135	$	6,473	$	1,957	$	(8,578	)	$	7,653
Current liabilities	$	60	$	207	$	480	$	284	$	—		$	1,031
Intercompany payable		—		—		2,992		169		(3,161	)		—
Other long-term liabilities		385		5,822		126		68		—			6,401
Stockholders' equity (deficit)		221		1,106		2,875		1,436		(5,417	)		221
Total liabilities and stockholders' equity	$	666	$	7,135	$	6,473	$	1,957	$	(8,578	)	$	7,653

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended July 1, 2017
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	152		$	1,325		$	429		$	—		$	1,906
Cost of goods sold		—			100			1,059			359			—			1,518
Selling, general and administrative		—			14			89			25			—			128
Amortization of intangibles		—			2			31			7			—			40
Restructuring and impairment charges		—			—			—			8			—			8
Operating income		—			36			146			30			—			212
Other expense (income), net		—			1			(1	)		(1	)		—			(1	)
Interest expense, net		—			5			47			16			—			68
Equity in net income of subsidiaries		(145	)		(109	)		—			—			254			—
Income before income taxes		145			139			100			15			(254	)		145
Income tax expense		38			32			—			6			(38	)		38
Net income	$	107		$	107		$	100		$	9		$	(216	)	$	107
Comprehensive net income	$	107		$	102		$	100		$	37		$	(216	)	$	130

	Quarterly Period Ended July 2, 2016
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	150		$	1,081		$	414		$	—		$	1,645
Cost of goods sold		—			140			834			322			—			1,296
Selling, general and administrative		—			6			93			30			—			129
Amortization of intangibles		—			2			27			6			—			35
Restructuring and impairment charges		—			—			1			5			—			6
Operating income		—			2			126			51			—			179
Other expense (income), net		—			8			(4	)		(18	)		—			(14	)
Interest expense, net		—			9			63			1			—			73
Equity in net income of subsidiaries		(120	)		(119	)		—			—			239			—
Income before income taxes		120			104			67			68			(239	)		120
Income tax expense		24			4			1			14			(19	)		24
Net income	$	96		$	100		$	66		$	54		$	(220	)	$	96
Comprehensive net income	$	96		$	98		$	65		$	38		$	(220	)	$	77

	Three Quarterly Periods Ended July 1, 2017
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	441		$	3,556		$	1,217		$	—		$	5,214
Cost of goods sold		—			333			2,860			984			—			4,177
Selling, general and administrative		—			45			251			77			—			373
Amortization of intangibles		—			5			87			21			—			113
Restructuring and impairment charges		—			—			10			8			—			18
Operating income		—			58			348			127			—			533
Other expense (income), net		—			15			1			2			—			18
Interest expense, net		—			17			138			48			—			203
Equity in net income of subsidiaries		(312	)		(252	)		—			—			564			—
Income before income taxes		312			278			209			77			(564	)		312
Income tax expense		82			48			—			34			(82	)		82
Net income	$	230		$	230		$	209		$	43		$	(482	)	$	230
Comprehensive net income	$	230		$	245		$	209		$	60		$	(482	)	$	262
Consolidating Statement of Cash Flows
Cash Flow from Operating Activities	$	—		$	31		$	420		$	129		$	—		$	580
Cash Flow from Investing Activities
Additions to  property, plant, and equipment		—			(11	)		(160	)		(30	)		—			(201	)
Proceeds from sale of assets		—			1			3			—			—			4
Contributions (to)/from subsidiaries		(26	)		(489	)		—			—			515			—
Intercompany		—			280			—			—			(280	)		—
Acquisition of business, net of cash acquired		—			—			(515	)		—			—			(515	)
Other investing activities, net		—			(1	)		—			—			—			(1	)
Net cash from investing activities		(26	)		(220	)		(672	)		(30	)		235			(713	)
Cash Flow from Financing Activities
Proceeds from long-term debt		—			545			—			—			—			545
Proceeds from issuance of common stock		26			—			—			—			—			26
Payment of tax receivable agreement		(60	)		—			—			—			—			(60	)
Repayments on long-term borrowings		—			(423	)		(3	)		(1	)		—			(427	)
Contribution from Parent		—			—			515			—			(515	)		—
Debt financing costs		—			(4	)		—			—			—			(4	)
Changes in intercompany balances		60			—			(255	)		(85	)		280			—
Net cash from financing activities		26			118			257			(86	)		(235	)		80
Effect of exchange rate changes on cash		—			—			—			5			—			5
Net change in cash		—			(71	)		5			18			—			(48	)
Cash and cash equivalents at beginning of period		—			102			5			216			—			323
Cash and cash equivalents at end of period	$	—		$	31		$	10		$	234		$	—		$	275

	Three Quarterly Periods Ended July 2, 2016
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	442		$	3,143		$	1,286		$	—		$	4,871
Cost of goods sold		—			373			2,490			1,022			—			3,885
Selling, general and administrative		—			89			251			81			—			421
Amortization of intangibles		—			6			77			23			—			106
Restructuring and impairment charges		—			—			23			6			—			29
Operating income		—			(26	)		302			154			—			430
Other expense (income), net		—			19			(11	)		(25	)		—			(17	)
Interest expense, net		—			27			158			37			—			222
Equity in net income of subsidiaries		(225	)		(258	)		—			—			483			—
Income before income taxes		225			186			155			142			(483	)		225
Income tax expense		66			23			2			36			(61	)		66
Net income	$	159		$	163		$	153		$	106		$	(422	)	$	159
Comprehensive net income	$	159		$	152		$	152		$	145		$	(422	)	$	186
Consolidating Statement of Cash Flows
Cash Flow from Operating Activities	$	—		$	23		$	382		$	162		$	—		$	567
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(13	)		(181	)		(34	)		—			(228	)
Proceeds from sale of assets		—			—			4			—			—			4
Contributions (to)/from subsidiaries		(20	)		(2,240	)		—			—			2,260			—
Intercompany		—			11			—			—			(11	)		—
Acquisition of business, net of cash acquired		—			—			(291	)		(1,992	)		—			(2,283	)
Other investing activities, net		—			(11	)		—			—			—			(11	)
Net cash from investing activities		(20	)		(2,253	)		(468	)		(2,026	)		2,249			(2,518	)
Cash Flow from Financing Activities
Proceeds from long-term debt		—			2,490			—			—			—			2,490
Repayments on long-term borrowings		—			(356	)		—			(34	)		—			(390	)
Proceeds from issuance of common stock		20			—			—			—			—			20
Payment of tax receivable agreement		(57	)		—			—			—			—			(57	)
Contribution from parent		—			—			291			1,969			(2,260	)		—
Debt financing costs		—			(38	)		—			—			—			(38	)
Purchase of non-controlling interest		—			—			(66	)		—			—			(66	)
Changes in intercompany balances		57			—			(110	)		42			11			—
Net cash from financing activities		20			2,096			115			1,977			(2,249	)		1,959
Effect of exchange rate changes on cash		—			—			—			—			—			—
Net change in cash		—			(134	)		29			113			—			8
Cash and cash equivalents at beginning of period		—			163			—			65			—			228
Cash and cash equivalents at end of period	$	—		$	29		$	29		$	178		$	—		$	236

XML

Acquisitions, AEP Industries Inc. (Details) - USD ($) shares in Millions, $ in Millions		1 Months Ended	3 Months Ended	9 Months Ended
		Jan. 31, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016	Oct. 01, 2016
Preliminary Allocation of Purchase Price [Abstract]
Goodwill				$ 2,782		$ 2,406
Term Loan due January 2024 [Member]
Acquisitions [Abstract]
Face amount of debt issued		$ 500
AEP [Member]
Acquisitions [Abstract]
Purchase price, net of cash acquired		$ 791
Number of shares issued (in shares)		6.4
Value of shares issued at time of closing		$ 324
Preliminary Allocation of Purchase Price [Abstract]
Working capital	[1]	133
Property and equipment		222
Intangible assets		214
Goodwill		350
Historical AEP debt assumed		(7)
Other assets and long-term liabilities		(121)
Step up of inventory to fair value		$ 5
Pro Forma Information [Abstract]
Pro forma net sales			$ 1,900	5,500	$ 5,700
Pro forma net income			$ 102	$ 232	$ 175

[1] Includes a $5 million step up of inventory to fair value.

XML

Acquisitions, Adchem Corp (Details) $ in Millions	1 Months Ended
	Jun. 30, 2017 USD ($)
Adchem [Member]
Acquisitions [Abstract]
Purchase price	$ 49

XML

Acquisitions, AVINTIV Inc. (Details) - USD ($) $ in Millions	1 Months Ended
	Oct. 31, 2015	Jul. 01, 2017
6.0% Second Priority Senior Secured Notes due October 2022 [Member]
Acquisitions [Abstract]
Face amount of debt issued	$ 400
Interest rate	6.00%	6.00%
Term Loan due October 2022 [Member]
Acquisitions [Abstract]
Face amount of debt issued	$ 2,100
Avintiv [Member]
Acquisitions [Abstract]
Percentage of capital stock acquired	100.00%
Purchase price, net of cash acquired	$ 2,260

XML

Restructuring and Impairment Charges, Restructuring Charges by Segment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Restructuring Charges [Abstract]
Restructuring charges	$ 8	$ 6	$ 18	$ 29
Consumer Packaging [Member]
Restructuring Charges [Abstract]
Restructuring charges	2	2	6	7
Health, Hygiene & Specialties [Member]
Restructuring Charges [Abstract]
Restructuring charges	4	4	8	20
Engineered Materials [Member]
Restructuring Charges [Abstract]
Restructuring charges	$ 2	$ 0	$ 4	$ 2

XML

Restructuring and Impairment Charges, Restructuring Accrual Activity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Restructuring Accrual [Roll Forward]
Beginning balance			$ 13
Charges	$ 8	$ 6	18	$ 29
Cash payments			(21)
Ending balance	10		10
Severance and Termination Benefits [Member]
Restructuring Accrual [Roll Forward]
Beginning balance			7
Charges			14
Cash payments			(15)
Ending balance	6		6
Facilities Exit Costs and Other [Member]
Restructuring Accrual [Roll Forward]
Beginning balance			6
Charges			4
Cash payments			(6)
Ending balance	$ 4		$ 4

XML

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Millions	Jul. 01, 2017	Oct. 01, 2016
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Employee compensation, payroll and other	$ 128	$ 152
Interest	33	53
Rebates	54	54
Restructuring	10	13
Accrued taxes	77	40
Tax receivable agreement obligation	101	60
Accrued operating expenses	95	77
Accrued expenses and other current liabilities	$ 498	$ 449

XML

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Other Long-Term Liabilities (Details) - USD ($) $ in Millions	Jul. 01, 2017	Oct. 01, 2016
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Lease retirement obligation	$ 36	$ 34
Sale-lease back deferred gain	24	26
Pension liability	82	88
Deferred purchase price	43	41
Tax receivable agreement obligation	22	114
Interest rate swaps	35	45
Other	69	69
Other long-term liabilities	$ 311	$ 417

XML

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Tax Receivable Agreement (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jan. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Payment of tax receivable agreement	$ 60	$ 60	$ 57
Percentage of cash savings paid annually under tax receivable agreement	85.00%
Apollo Global Management, LLC [Member]
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Payment of tax receivable agreement	$ 48

XML

Long-Term Debt, Summary of Long-Term Debt (Details) - USD ($) $ in Millions	9 Months Ended
	Jul. 01, 2017	Oct. 01, 2016	Oct. 31, 2015
Long-term Debt [Abstract]
Debt discounts and deferred fees	$ (52)	$ (58)
Capital leases and other	137	153
Total long-term debt	5,891	5,755
Current portion of long-term debt	(34)	(43)
Long-term debt, less current portion	5,857	5,712
Term Loan due February 2020 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 1,148	1,351
Maturity date	Feb. 29, 2020
Term Loan due January 2021 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 814	814
Maturity date	Jan. 31, 2021
Term Loan due October 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 1,695	1,895
Maturity date	Oct. 31, 2022
Term Loan due January 2024 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 499	0
Maturity date	Jan. 31, 2024
Revolving Line of Credit [Member]
Long-term Debt [Abstract]
Long-term debt	$ 50	0
Maturity date	May 31, 2020
5 1/8% Second Priority Senior Secured Notes due July 2023 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 700	700
Interest rate	5.125%
Maturity date	Jul. 31, 2023
5 1/2% Second Priority Senior Secured Notes due May 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 500	500
Interest rate	5.50%
Maturity date	May 31, 2022
6.0% Second Priority Senior Secured Notes due October 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 400	$ 400
Interest rate	6.00%		6.00%
Maturity date	Oct. 31, 2022

XML

Long-Term Debt, Term Loans (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended	9 Months Ended
	Jan. 31, 2017	Jul. 01, 2017	Jul. 01, 2017	Jul. 02, 2016	Oct. 31, 2015
Long-Term Debt [Abstract]
Repayments on long-term debt			$ 427	$ 390
Other (Income) Expense, Net [Member]
Long-Term Debt [Abstract]
Loss on extinguishment of debt			$ (3)
Term Loan due October 2022 [Member]
Long-Term Debt [Abstract]
Face amount of debt issued					$ 2,100
Maturity date			Oct. 31, 2022
Term Loan due October 2022 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate		2.50%
Term Loan due January 2024 [Member]
Long-Term Debt [Abstract]
Face amount of debt issued	$ 500
Maturity date			Jan. 31, 2024
Term Loan due January 2024 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	2.50%
Term Loan due January 2021 [Member]
Long-Term Debt [Abstract]
Maturity date			Jan. 31, 2021
Term Loan due January 2021 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate		2.25%
Term Loan due February 2020 [Member]
Long-Term Debt [Abstract]
Maturity date			Feb. 29, 2020
Additional debt discounts and deferred financing fees related to incremental assumption agreements and amendments			$ 9
Term Loan due February 2020 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate		2.25%

XML

Financial Instruments and Fair Value Measurements, Active Interest Rate Swap Arrangements (Details) - USD ($) $ in Millions	1 Months Ended	9 Months Ended
	Jun. 28, 2013	Jul. 01, 2017	Feb. 28, 2017	Jan. 31, 2017	Sep. 30, 2015	Mar. 31, 2014	Feb. 28, 2013
Interest Rate Swap - February 2013 [Member]
Active Interest Rate Swap Arrangements [Abstract]
Notional amount of swap							$ 1,000
Cash received for settlement of derivative contract	$ 16
Interest Rate Swap - March 2014 [Member]
Active Interest Rate Swap Arrangements [Abstract]
Notional amount of swap						$ 1,000
Interest Rate Swap - September 2015 [Member]
Active Interest Rate Swap Arrangements [Abstract]
Notional amount of swap					$ 1,000
Interest Rate Swap - Modified February 2017 [Member]
Active Interest Rate Swap Arrangements [Abstract]
Fixed annual rate of swap			1.519%
Interest Rate Swap - Modified February 2017 [Member] | LIBOR [Member]
Active Interest Rate Swap Arrangements [Abstract]
Term of variable rate		1 month
Interest Rate Swap - January 2017 [Member]
Active Interest Rate Swap Arrangements [Abstract]
Notional amount of swap				$ 450
Fixed annual rate of swap				2.00%
Interest Rate Swap - January 2017 [Member] | LIBOR [Member]
Active Interest Rate Swap Arrangements [Abstract]
Term of variable rate		1 month
Interest Rate Swap - February 2017 [Member]
Active Interest Rate Swap Arrangements [Abstract]
Notional amount of swap			$ 1,000
Fixed annual rate of swap			2.3785%
Interest Rate Swap - February 2017 [Member] | LIBOR [Member]
Active Interest Rate Swap Arrangements [Abstract]
Term of variable rate		1 month

XML

Financial Instruments and Fair Value Measurements, Fair Value of Derivatives and Location on Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Jul. 01, 2017	Oct. 01, 2016
Foreign Currency Forward Contracts [Member] | Not Designated | Other Assets [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 3	$ 3
Interest Rate Swaps [Member] | Not Designated | Other Assets [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	17	0
Interest Rate Swaps [Member] | Not Designated | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	17	0
Interest Rate Swaps [Member] | Designated | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 18	$ 35

XML

Financial Instruments and Fair Value Measurements, Effect of Derivatives on Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Derivative Instruments [Abstract]
Amortization related to unrealized losses in Accumulated other comprehensive loss for next 12 months			$ (2)
Interest Rate Swaps [Member] | Interest Expense, Net [Member]
Derivative Instruments [Abstract]
Loss on derivative instruments	$ 5	$ 6	15	$ 10
Foreign Currency Forward Contracts [Member] | Other (Income) Expense, Net [Member]
Derivative Instruments [Abstract]
Loss on derivative instruments	$ 1	$ 3	$ 0	$ 9

XML

Financial Instruments and Fair Value Measurements, Assets Measured at Fair Value on Non-Recurring Basis (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended	12 Months Ended
	Jul. 01, 2017	Jul. 01, 2017	Oct. 01, 2016
Impairment [Abstract]
Indefinite-lived trademarks		$ 0	$ 0
Goodwill		0	0
Definite lived intangible assets		0	0
Property, plant, and equipment		0	3
Impairment charges		0	3
Fair Value Adjustment [Abstract]
Fair value of marketable long-term indebtedness in excess of book value	$ 76
Fair Value on Nonrecurring Basis [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248	248
Goodwill	2,782	2,782	2,406
Definite lived intangible assets	1,066	1,066	952
Property, plant, and equipment	2,375	2,375	2,224
Total	6,471	6,471	5,830
Fair Value on Nonrecurring Basis [Member] | Level 1 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0	0
Goodwill	0	0	0
Definite lived intangible assets	0	0	0
Property, plant, and equipment	0	0	0
Total	0	0	0
Fair Value on Nonrecurring Basis [Member] | Level 2 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0	0
Goodwill	0	0	0
Definite lived intangible assets	0	0	0
Property, plant, and equipment	0	0	0
Total	0	0	0
Fair Value on Nonrecurring Basis [Member] | Level 3 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248	248
Goodwill	2,782	2,782	2,406
Definite lived intangible assets	1,066	1,066	952
Property, plant, and equipment	2,375	2,375	2,224
Total	$ 6,471	$ 6,471	$ 5,830

XML

Income Taxes (Details)	3 Months Ended	9 Months Ended
	Jul. 01, 2017	Jul. 01, 2017
Income Taxes [Abstract]
Effective tax rate	26.00%	26.00%
Share based compensation excess tax benefit	(9.00%)	(9.00%)
State valuation allowance release		(3.00%)
State taxes		2.00%
Foreign valuation allowance		2.00%

XML

Operating Segments, Selected Information by Reportable Segment (Details) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2017 USD ($)	Jul. 02, 2016 USD ($)	Jul. 01, 2017 USD ($) Segment	Jul. 02, 2016 USD ($)	Oct. 01, 2016 USD ($)
Selected Information by Reportable Segment [Abstract]
Number of reporting segments | Segment			3
Net sales	$ 1,906	$ 1,645	$ 5,214	$ 4,871
Operating income	212	179	533	430
Depreciation and amortization	132	120	383	390
Total assets	8,545		8,545		$ 7,653
Operating Segment [Member] | Consumer Packaging [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	614	631	1,752	1,845
Operating income	60	58	150	156
Depreciation and amortization	56	61	174	183
Total assets	3,268		3,268		3,315
Operating Segment [Member] | Health, Hygiene & Specialties [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	606	606	1,773	1,807
Operating income	53	69	164	140
Depreciation and amortization	46	38	136	143
Total assets	3,441		3,441		3,504
Operating Segment [Member] | Engineered Materials [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	686	408	1,689	1,219
Operating income	99	52	219	134
Depreciation and amortization	30	21	73	64
Total assets	$ 1,836		$ 1,836		$ 834
Realignment Adjustment [Member] | Consumer Packaging [Member]
Selected Information by Reportable Segment [Abstract]
Net sales		(73)		(230)
Realignment Adjustment [Member] | Health, Hygiene & Specialties [Member] | Specialties [Member]
Selected Information by Reportable Segment [Abstract]
Net sales		39		108
Realignment Adjustment [Member] | Engineered Materials [Member]
Selected Information by Reportable Segment [Abstract]
Net sales		73		230
Realignment Adjustment [Member] | Engineered Materials [Member] | Retail & Industrial [Member]
Selected Information by Reportable Segment [Abstract]
Net sales		$ (39)		$ (108)

XML

Operating Segments, Selected Information by Geography (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Selected Information by Geography [Abstract]
Net sales	$ 1,906	$ 1,645	$ 5,214	$ 4,871
Long-lived assets	6,523	5,861	6,523	5,861
North America [Member]
Selected Information by Geography [Abstract]
Net sales	1,591	1,329	4,289	3,939
Long-lived assets	5,420	4,724	5,420	4,724
South America [Member]
Selected Information by Geography [Abstract]
Net sales	85	88	246	247
Long-lived assets	360	386	360	386
Europe [Member]
Selected Information by Geography [Abstract]
Net sales	165	166	482	505
Long-lived assets	459	462	459	462
Asia [Member]
Selected Information by Geography [Abstract]
Net sales	65	62	197	180
Long-lived assets	$ 284	$ 289	$ 284	$ 289

XML

Operating Segments, Selected Information by Product Line (Details) - Net Sales [Member]	3 Months Ended		9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Consumer Packaging [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Consumer Packaging [Member] | Rigid Open Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	44.00%	43.00%	42.00%	42.00%
Consumer Packaging [Member] | Rigid Closed Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	56.00%	57.00%	58.00%	58.00%
Health, Hygiene & Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Health, Hygiene & Specialties [Member] | Health [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	22.00%	21.00%	22.00%	20.00%
Health, Hygiene & Specialties [Member] | Hygiene [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	44.00%	45.00%	44.00%	45.00%
Health, Hygiene & Specialties [Member] | Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	34.00%	34.00%	34.00%	35.00%
Engineered Materials [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%	100.00%
Engineered Materials [Member] | Core Films [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	43.00%	72.00%	51.00%	71.00%
Engineered Materials [Member] | Retail & Industrial [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	57.00%	28.00%	49.00%	29.00%

XML

Operating Segments, Goodwill (Details) $ in Millions	9 Months Ended
	Jul. 01, 2017 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 2,406
Segment reorganization	0
Acquisition, net	376
Foreign currency translation adjustment	0
Goodwill, ending balance	2,782
Operating Segment [Member] | Consumer Packaging [Member]
Goodwill [Roll Forward]
Goodwill, beginning balance	1,520
Segment reorganization	(110)
Acquisition, net	0
Foreign currency translation adjustment	0
Goodwill, ending balance	1,410
Operating Segment [Member] | Health, Hygiene & Specialties [Member]
Goodwill [Roll Forward]
Goodwill, beginning balance	801
Segment reorganization	7
Acquisition, net	0
Foreign currency translation adjustment	0
Goodwill, ending balance	808
Operating Segment [Member] | Engineered Materials [Member]
Goodwill [Roll Forward]
Goodwill, beginning balance	85
Segment reorganization	103
Acquisition, net	376
Foreign currency translation adjustment	0
Goodwill, ending balance	$ 564

XML

Basic and Diluted Net Income per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Basic and Diluted Net Income per Share [Abstract]
Antidilutive shares excluded from computation of earnings per share (in shares)	0.0		0.0
Numerator [Abstract]
Net income	$ 107	$ 96	$ 230	$ 159
Denominator [Abstract]
Weighted average common shares outstanding - basic (in shares)	129.9	121.1	126.6	120.5
Dilutive shares (in shares)	5.3	4.8	4.8	3.4
Weighted average common and common equivalent shares outstanding - diluted (in shares)	135.2	125.9	131.4	123.9
Per Common Share Income [Abstract]
Basic (in dollars per share)	$ 0.82	$ 0.79	$ 1.82	$ 1.32
Diluted (in dollars per share)	$ 0.79	$ 0.76	$ 1.75	$ 1.28

XML

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
De-designated hedges			$ 0
Other comprehensive income (loss) before reclassifications			22	$ 9
Net amount reclassified from accumulated other comprehensive income (loss)			18	10
Provision for income taxes related to other comprehensive income items	$ 0	$ 1	(8)	8
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(148)	(119)
Ending balance	(116)	(92)	(116)	(92)
Currency Translation [Member]
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(82)	(81)
De-designated hedges			0
Other comprehensive income (loss) before reclassifications			4	39
Net amount reclassified from accumulated other comprehensive income (loss)			0	0
Provision for income taxes related to other comprehensive income items			0	0
Ending balance	(78)	(42)	(78)	(42)
Defined Benefit Pension and Retiree Health Benefit Plans [Member]
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(44)	(25)
De-designated hedges			0
Other comprehensive income (loss) before reclassifications			13	0
Net amount reclassified from accumulated other comprehensive income (loss)			0	0
Provision for income taxes related to other comprehensive income items			0	0
Ending balance	(31)	(25)	(31)	(25)
Interest Rate Swaps Designated as Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			(31)	(23)
De-designated hedges			17
Other comprehensive income (loss) before reclassifications			5	(30)
Net amount reclassified from accumulated other comprehensive income (loss)			17	10
Provision for income taxes related to other comprehensive income items			(8)	8
Ending balance	0	(35)	0	(35)
Interest Rate Swaps Not Designated as Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance			9	10
De-designated hedges			(17)
Other comprehensive income (loss) before reclassifications			0	0
Net amount reclassified from accumulated other comprehensive income (loss)			1	0
Provision for income taxes related to other comprehensive income items			0	0
Ending balance	$ (7)	$ 10	$ (7)	$ 10

XML

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Balance Sheet (Details) - USD ($) $ in Millions	9 Months Ended
	Jul. 01, 2017	Oct. 01, 2016
Guarantor and Non-Guarantor Financial Information [Abstract]
Percentage ownership in guarantor subsidiaries	100.00%
Assets [Abstract]
Current assets	$ 2,022	$ 1,792
Intercompany receivable	0	0
Property, plant, and equipment, net	2,375	2,224
Other assets	4,148	3,637
Total assets	8,545	7,653
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	1,113	1,031
Intercompany payable	0	0
Other long-term liabilities	6,584	6,401
Stockholders' equity (deficit)	848	221
Total liabilities and stockholders' equity	8,545	7,653
Eliminations [Member]
Assets [Abstract]
Current assets	0	0
Intercompany receivable	(3,030)	(3,161)
Property, plant, and equipment, net	0	0
Other assets	(7,038)	(5,417)
Total assets	(10,068)	(8,578)
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	0	0
Intercompany payable	(3,030)	(3,161)
Other long-term liabilities	0	0
Stockholders' equity (deficit)	(7,038)	(5,417)
Total liabilities and stockholders' equity	(10,068)	(8,578)
Parent [Member]
Assets [Abstract]
Current assets	0	0
Intercompany receivable	518	364
Property, plant, and equipment, net	0	0
Other assets	868	302
Total assets	1,386	666
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	101	60
Intercompany payable	0	0
Other long-term liabilities	437	385
Stockholders' equity (deficit)	848	221
Total liabilities and stockholders' equity	1,386	666
Issuer [Member]
Assets [Abstract]
Current assets	80	161
Intercompany receivable	2,512	2,797
Property, plant, and equipment, net	74	76
Other assets	5,217	4,101
Total assets	7,883	7,135
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	167	207
Intercompany payable	66	0
Other long-term liabilities	5,976	5,822
Stockholders' equity (deficit)	1,674	1,106
Total liabilities and stockholders' equity	7,883	7,135
Guarantor Subsidiaries [Member]
Assets [Abstract]
Current assets	1,188	945
Intercompany receivable	0	0
Property, plant, and equipment, net	1,591	1,434
Other assets	4,578	4,094
Total assets	7,357	6,473
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	563	480
Intercompany payable	2,819	2,992
Other long-term liabilities	105	126
Stockholders' equity (deficit)	3,870	2,875
Total liabilities and stockholders' equity	7,357	6,473
Non-Guarantor Subsidiaries [Member]
Assets [Abstract]
Current assets	754	686
Intercompany receivable	0	0
Property, plant, and equipment, net	710	714
Other assets	523	557
Total assets	1,987	1,957
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	282	284
Intercompany payable	145	169
Other long-term liabilities	66	68
Stockholders' equity (deficit)	1,494	1,436
Total liabilities and stockholders' equity	$ 1,987	$ 1,957

XML

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Statements of Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Condensed Consolidated Statements of Operations [Abstract]
Net sales	$ 1,906	$ 1,645	$ 5,214	$ 4,871
Cost of goods sold	1,518	1,296	4,177	3,885
Selling, general and administrative	128	129	373	421
Amortization of intangibles	40	35	113	106
Restructuring and impairment charges	8	6	18	29
Operating income	212	179	533	430
Other expense (income), net	(1)	(14)	18	(17)
Interest expense, net	68	73	203	222
Equity in net income of subsidiaries	0	0	0	0
Income before income taxes	145	120	312	225
Income tax expense (benefit)	38	24	82	66
Net income	107	96	230	159
Comprehensive net income (loss)	130	77	262	186
Eliminations [Member]
Condensed Consolidated Statements of Operations [Abstract]
Net sales	0	0	0	0
Cost of goods sold	0	0	0	0
Selling, general and administrative	0	0	0	0
Amortization of intangibles	0	0	0	0
Restructuring and impairment charges	0	0	0	0
Operating income	0	0	0	0
Other expense (income), net	0	0	0	0
Interest expense, net	0	0	0	0
Equity in net income of subsidiaries	254	239	564	483
Income before income taxes	(254)	(239)	(564)	(483)
Income tax expense (benefit)	(38)	(19)	(82)	(61)
Net income	(216)	(220)	(482)	(422)
Comprehensive net income (loss)	(216)	(220)	(482)	(422)
Parent [Member]
Condensed Consolidated Statements of Operations [Abstract]
Net sales	0	0	0	0
Cost of goods sold	0	0	0	0
Selling, general and administrative	0	0	0	0
Amortization of intangibles	0	0	0	0
Restructuring and impairment charges	0	0	0	0
Operating income	0	0	0	0
Other expense (income), net	0	0	0	0
Interest expense, net	0	0	0	0
Equity in net income of subsidiaries	(145)	(120)	(312)	(225)
Income before income taxes	145	120	312	225
Income tax expense (benefit)	38	24	82	66
Net income	107	96	230	159
Comprehensive net income (loss)	107	96	230	159
Issuer [Member]
Condensed Consolidated Statements of Operations [Abstract]
Net sales	152	150	441	442
Cost of goods sold	100	140	333	373
Selling, general and administrative	14	6	45	89
Amortization of intangibles	2	2	5	6
Restructuring and impairment charges	0	0	0	0
Operating income	36	2	58	(26)
Other expense (income), net	1	8	15	19
Interest expense, net	5	9	17	27
Equity in net income of subsidiaries	(109)	(119)	(252)	(258)
Income before income taxes	139	104	278	186
Income tax expense (benefit)	32	4	48	23
Net income	107	100	230	163
Comprehensive net income (loss)	102	98	245	152
Guarantor Subsidiaries [Member]
Condensed Consolidated Statements of Operations [Abstract]
Net sales	1,325	1,081	3,556	3,143
Cost of goods sold	1,059	834	2,860	2,490
Selling, general and administrative	89	93	251	251
Amortization of intangibles	31	27	87	77
Restructuring and impairment charges	0	1	10	23
Operating income	146	126	348	302
Other expense (income), net	(1)	(4)	1	(11)
Interest expense, net	47	63	138	158
Equity in net income of subsidiaries	0	0	0	0
Income before income taxes	100	67	209	155
Income tax expense (benefit)	0	1	0	2
Net income	100	66	209	153
Comprehensive net income (loss)	100	65	209	152
Non-Guarantor Subsidiaries [Member]
Condensed Consolidated Statements of Operations [Abstract]
Net sales	429	414	1,217	1,286
Cost of goods sold	359	322	984	1,022
Selling, general and administrative	25	30	77	81
Amortization of intangibles	7	6	21	23
Restructuring and impairment charges	8	5	8	6
Operating income	30	51	127	154
Other expense (income), net	(1)	(18)	2	(25)
Interest expense, net	16	1	48	37
Equity in net income of subsidiaries	0	0	0	0
Income before income taxes	15	68	77	142
Income tax expense (benefit)	6	14	34	36
Net income	9	54	43	106
Comprehensive net income (loss)	$ 37	$ 38	$ 60	$ 145

XML

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Statements of Cash Flows (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jan. 02, 2016	Jul. 01, 2017	Jul. 02, 2016
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities		$ 580	$ 567
Cash Flows from Investing Activities [Abstract]
Additions to property, plant and equipment		(201)	(228)
Proceeds from sale of assets		4	4
Contributions (to)/from subsidiaries		0	0
Intercompany		0	0
Acquisition of business net of cash acquired		(515)	(2,283)
Other investing activities, net		(1)	(11)
Net cash from investing activities		(713)	(2,518)
Cash Flows from Financing Activities [Abstract]
Proceeds from long-term debt		545	2,490
Proceeds from issuance of common stock		26	20
Payment of tax receivable agreement	$ (60)	(60)	(57)
Repayments on long-term borrowings		(427)	(390)
Contribution from Parent		0	0
Debt financing costs		(4)	(38)
Purchase of non-controlling interest		0	(66)
Changes in intercompany balances		0	0
Net cash from financing activities		80	1,959
Effect of exchange rate changes on cash		5	0
Net change in cash		(48)	8
Cash and cash equivalents at beginning of period	228	323	228
Cash and cash equivalents at end of period		275	236
Eliminations [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities		0	0
Cash Flows from Investing Activities [Abstract]
Additions to property, plant and equipment		0	0
Proceeds from sale of assets		0	0
Contributions (to)/from subsidiaries		515	2,260
Intercompany		(280)	(11)
Acquisition of business net of cash acquired		0	0
Other investing activities, net		0	0
Net cash from investing activities		235	2,249
Cash Flows from Financing Activities [Abstract]
Proceeds from long-term debt		0	0
Proceeds from issuance of common stock		0	0
Payment of tax receivable agreement		0	0
Repayments on long-term borrowings		0	0
Contribution from Parent		(515)	(2,260)
Debt financing costs		0	0
Purchase of non-controlling interest			0
Changes in intercompany balances		280	11
Net cash from financing activities		(235)	(2,249)
Effect of exchange rate changes on cash		0	0
Net change in cash		0	0
Cash and cash equivalents at beginning of period	0	0	0
Cash and cash equivalents at end of period		0	0
Parent [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities		0	0
Cash Flows from Investing Activities [Abstract]
Additions to property, plant and equipment		0	0
Proceeds from sale of assets		0	0
Contributions (to)/from subsidiaries		(26)	(20)
Intercompany		0	0
Acquisition of business net of cash acquired		0	0
Other investing activities, net		0	0
Net cash from investing activities		(26)	(20)
Cash Flows from Financing Activities [Abstract]
Proceeds from long-term debt		0	0
Proceeds from issuance of common stock		26	20
Payment of tax receivable agreement		(60)	(57)
Repayments on long-term borrowings		0	0
Contribution from Parent		0	0
Debt financing costs		0	0
Purchase of non-controlling interest			0
Changes in intercompany balances		60	57
Net cash from financing activities		26	20
Effect of exchange rate changes on cash		0	0
Net change in cash		0	0
Cash and cash equivalents at beginning of period	0	0	0
Cash and cash equivalents at end of period		0	0
Issuer [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities		31	23
Cash Flows from Investing Activities [Abstract]
Additions to property, plant and equipment		(11)	(13)
Proceeds from sale of assets		1	0
Contributions (to)/from subsidiaries		(489)	(2,240)
Intercompany		280	11
Acquisition of business net of cash acquired		0	0
Other investing activities, net		(1)	(11)
Net cash from investing activities		(220)	(2,253)
Cash Flows from Financing Activities [Abstract]
Proceeds from long-term debt		545	2,490
Proceeds from issuance of common stock		0	0
Payment of tax receivable agreement		0	0
Repayments on long-term borrowings		(423)	(356)
Contribution from Parent		0	0
Debt financing costs		(4)	(38)
Purchase of non-controlling interest			0
Changes in intercompany balances		0	0
Net cash from financing activities		118	2,096
Effect of exchange rate changes on cash		0	0
Net change in cash		(71)	(134)
Cash and cash equivalents at beginning of period	163	102	163
Cash and cash equivalents at end of period		31	29
Guarantor Subsidiaries [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities		420	382
Cash Flows from Investing Activities [Abstract]
Additions to property, plant and equipment		(160)	(181)
Proceeds from sale of assets		3	4
Contributions (to)/from subsidiaries		0	0
Intercompany		0	0
Acquisition of business net of cash acquired		(515)	(291)
Other investing activities, net		0	0
Net cash from investing activities		(672)	(468)
Cash Flows from Financing Activities [Abstract]
Proceeds from long-term debt		0	0
Proceeds from issuance of common stock		0	0
Payment of tax receivable agreement		0	0
Repayments on long-term borrowings		(3)	0
Contribution from Parent		515	291
Debt financing costs		0	0
Purchase of non-controlling interest			(66)
Changes in intercompany balances		(255)	(110)
Net cash from financing activities		257	115
Effect of exchange rate changes on cash		0	0
Net change in cash		5	29
Cash and cash equivalents at beginning of period	0	5	0
Cash and cash equivalents at end of period		10	29
Non-Guarantor Subsidiaries [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities		129	162
Cash Flows from Investing Activities [Abstract]
Additions to property, plant and equipment		(30)	(34)
Proceeds from sale of assets		0	0
Contributions (to)/from subsidiaries		0	0
Intercompany		0	0
Acquisition of business net of cash acquired		0	(1,992)
Other investing activities, net		0	0
Net cash from investing activities		(30)	(2,026)
Cash Flows from Financing Activities [Abstract]
Proceeds from long-term debt		0	0
Proceeds from issuance of common stock		0	0
Payment of tax receivable agreement		0	0
Repayments on long-term borrowings		(1)	(34)
Contribution from Parent		0	1,969
Debt financing costs		0	0
Purchase of non-controlling interest			0
Changes in intercompany balances		(85)	42
Net cash from financing activities		(86)	1,977
Effect of exchange rate changes on cash		5	0
Net change in cash		18	113
Cash and cash equivalents at beginning of period	$ 65	216	65
Cash and cash equivalents at end of period		$ 234	$ 178